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GENERAL I N T R O D U C T I O N 
Structure, assembly 
and functions of the 
20S proteasome 
CHAPTER I 
Introduction 
Many cellular processes, like cell cycle, metabolic pathways and gene expression, proceed in a 
coordinate fashion, tightly regulated by the activity of various key proteins. Environmental 
conditions affect these processes via the activity of regulatory proteins such as kinases, cyclins 
and inhibitors. The amount, and hence the activity, of the regulatory key proteins is 
frequently modulated by their production rate via transcriptional and/or translational 
mechanisms. Activity of these regulators can also be manipulated by posttranslational 
modifications like phosphorylation. In recent years it has become apparent that also 
controlled protein degradation is an important and efficient way to regulate the activity of 
these proteins. Selective degradation has several advantages, such as speed and irreversibility, 
over other regulatory controls. The ubiquitin-proteasome-dependent proteolysis system is the 
major component of this process. The ubiquitin system selectively recognizes and marks 
target proteins by covalent linkage of multiple molecules of a small conserved protein, called 
ubiquitin (1,2). Polyubiquitinated proteins are degraded by the 26S proteasome. This is a 
large multicatalytic protease complex of about 2000 kDa composed of two multi-subunit 
complexes: the 20S proteasome constituting the proteolytic core and the 19S regulatory 
complex (also called PA700), which confers polyubiquitin-binding and energy generation. 
A simplified model of the ubiquitin pathway is depicted in Fig. 1. 
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Fig. I . Schematic representation 
of the proteasome-ubiquitin 
pathway. Ubiquitin is first activated 
by an ubiquitin activating enzyme (UBA 
or El) and passed on to a ubiquitin 
conjugating protein (UBC or E2) 
Ubiquitin is then directly or with the 
help of ubiquitin ligases (E3), linked via 
an isopeptide bond to a lysine residue 
of the substrate protein Polyubiquiti-
nated proteins are recognized and 
selectively degraded by the 26S 
proteasome yielding reusable ubiquitin 
molecules and peptides of 5-15 amino 
acids Conversion of a protein into a 
substrate for ubiquitination (certain 
cases) can occur after post-trans-
lational modification or association 
with ancillary factors Proteins can also 
be recognized by an E3 ubiquitin 
ligase without prior modification or 
association (adapted from Ciechanover 
et al (88)) 
Peptides 
Functions of the proteasome-ubiquit in-pathway 
The proteasome-ubiquitin-pathway is involved in a wide variety of cellular processes, which 
can be placed into two basic categories general protein turnover and the removal of specific 
short-lived regulator proteins The first category comprises the degradation of the bulk of 
long-lived cytoplasmatic proteins (3), misfolded proteins (4), and at least some LR-associated 
proteins ((5), eg Œ T R (6,7), misfolded proteins (8,9), major histocompatibility complex 
(MHC) class I molecules upon human cytomegalovirus infection (10,11)) The second 
category of protein breakdown mediated by the proteasome-ubiquitin-pathway encompasses 
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the regulation of the amount of certain transcriptional regulators {e.g. p53, c-Jun, c-Mos, 11 
N F - K B , MAT a2 repressor (12,13)), factors of different metabolic pathways (fructose-1,6-
biphosphatase, ornithine decarboxylase (13)), and key proteins in the cell cycle (chapter 5, 
(14,15)). The protcasome-ubiquitin-pathway is also involved in the induction and progres­
sion of apoptosis, but its targets are not known (16-19). Another important function of this 
degradation system is the generation of peptides for antigen presentation. Proteasomcs cut 
polypeptides, like viral proteins, into peptides of 8-9 amino acid residues, which are 
transported to the ER and bind to M H C class I molecules. These complexes present the 
peptides to the cytotoxic T-cells of the immune system (20). 
In this thesis the role of the proteasome-ubiquitin-pathway in the cell cycle was investigated. 
In cell cycle progression, the activity of several regulatory proteins is sequentially modulated 
to assure correct timing and order of events. An important family of proteins in this process 
are the cyclins. They are present only during a defined stage of the cell cycle. Production of 
these proteins is generally rapid and occurs at a certain point of the cycle. However, removal 
of cyclins is also essential to allow progression through a step downstream in the cycle. An 
example is cyclin B, which is expressed late in S-phase and the protein accumulates during 
G2- and early M-phase. It is important for initiation of the G2-M transition. For mitosis to 
Gl-phase transition degradation of cyclin В is essential. Cyclin В ubiquitination occurs via a 
large ubiquitin ligase (or E3) complex (see Fig. 1) called anaphase promoting factor (APC) 
or cyclosome. The APC-complex is also involved in the degradation of other factors, which 
inhibit M-Gl transition (for reviews see (14,15)). Also the breakdown of inhibitors of 
certain cell cycle checkpoints is mediated by the proteasome-ubiquitin-pathway. At the GO-S 
or Gl-S transition ubiquitination and subsequent degradation of p27 (also called SIC1), 
which is an inhibitor of a CDK-cyclin complex, is crucial. In this process the ubiquitin 
conjugating enzyme (or E2) CDC34 is involved, which also ubiquitinates some Gl-cyclins 
((21), for reviews see (14,15)). 
The 20S proteasome 
As mentioned before, the degrading component of the ubiquitin-dependent proteolysis is the 
26S proteasome. The 20S proteasome is the catalytic core of this complex. This particle is 
highly conserved and can be in found in eukaryotes, archaebacteria (22) and some 
eubacteria (23). In eukaryotes the amount of proteasomes can constitute up to 1% of the cell 
protein content, depending on the average breakdown rates of the organ (24). Proteasomes 
are localized in the nucleus and the cytosol (25), sometimes colocalized or associated with the 
cytoskeleton (26). Despite the abundance and characteristic properties of the proteasome, 
progress in the understanding of the function and mode of action of the particle has, until 
recently, been slow. The 20S proteasome has independently been discovered by groups 
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12 working in different fields and hence given different names. Scherrer and colleagues observed 
ring-shaped particles in ribosome-free mRNA preparations (27). In 1984 this particle was 
called prosome referring to its presumed role in programming mRNA translation (28). 
Demartino and Goldberg isolated a 700 kDa "neutral protease" from rat liver (29). In 1980 
Wilk and Orlowski isolated a large protease complex from the pituitary possessing three 
different catalytic activities and called multicatalytic protease (30,31)· Monaco and McDevitt 
immuno-precipitated complexes consisting of "low-molecular-weight proteins (LMP's)" with 
a possible role in antigen presentation (32). Altogether this complex has been given 21 
Table I. Nomenclature and molecular masses of proteasomal subunits. The systematic 
nomenclature is based on the position of the subunits in the yeast proteasome as recently 
proposed by Groll and coworkers (46).The molecular masses of the primary gene products were 
obtained from (49).Values in brackets correspond to the molecular mass of the processed 
(mature) subunit 
systematic 
name 
a l 
a2 
a3 
a4 
aS 
a6 
a7 
PI 
ßl i 
ß2 
ß2i 
ß3 
ß4 
PS 
ß5i 
P6 
P7 
Human gene 
HsPROS27/Hslota 
HsC3 
HsC9 
XAPC7/HsC6 
HsZeta 
HsPROS30/HsC2 
HsC8 
HsDelta/Y 
LMP2 
Ζ 
MECLI 
HsC 10-11 
HsC7-l 
MBI/X 
LMP7 
HsC5 
HsBPROS26/HsN3 
yeast gene 
C7/PRS2 
Y7 
YI3 
PRE6 
PUP2 
PRE5 
CI/PRSI 
PRE3 
PUPI 
PUP3 
PRE 1 /С 11 
PRE2 
C5/PRS3 
Pre4 
Molecular mass of 
human subunit (kDa) 
27.4 
25.9 
29.5 
27.9 
26.4 
30.2 
28.4 
25.3(21.9) 
23.2 (20.9) 
30.0 (24.5) 
28.9 (23.8) 
22.9 
22.8 
nd (22.4) 
30.4(21.2) 
26.5 (23.3) 
29.2 (24.4) 
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different names in the literature. Since all particles were shown to be identical (33-35), the 13 
name "proteasome", which is now generally accepted, was proposed referring to its 
proteolytic and particulate nature (33). 
Structure and components of the 20S proteasome 
The 20S proteasome has a cylindrical structure, 14.8 nm in length and 11.3 nm in diameter. 
It is composed of 28 subunits arranged in four stacked rings resulting in a molecular mass of 
about 700 kDa. This overall architecture is conserved from bacteria to man (22,36). The 
proteasome isolated from the archaebacterium Thermoplasma acidophilum contains two 
different but related subunits, α and β, located in the outer rings and the inner rings, respec­
tively (22,37,38). In eukaryotes at least 14 different subunits, ranging from 21 kDa to 32 
kDa, are present in the complex. Based on the sequence homology with the T. acidophilum 
a- or ß-subunit, the eukaryotic subunits can be divided into α-type and ß-type, respectively 
(Table I, (39-41)). Like in T. acidophilum, immuno-EM studies revealed that the eukaryotic 
α-type subunits reside in the outer rings and the ß-type subunits in the inner rings. 
Furthermore, these studies indicated that in the eukaryotic 20S proteasome seven different 
subunits constitute α-ring, each subunit located at a defined position (42-46). Therefore, the 
archaebacterial proteasome forms an aj^^a-j complex, whereas the eukaryotic proteasome 
assembles as an αι-7βι-7βι_7αι_7 particle. Both are composed of two identical halves, related to 
each other by C2 symmetry. On averaged electron micrographs, a- and ß-rings seem about 
25° out of register which is approximately half a subunit, whereas the two adjacent ß-rings 
are apparently in register relative to each other (47,48). Only very recently the crystal 
structure of the yeast 20S proteasome has been solved (Fig. 2 (46)). The new insight into the 
proteasomal structure, obtained from this study, is discussed at the end of this section and 
observations concerning the catalytic sites and mechanism are described in the proteolytic 
activity section. 
In yeast seven different a- and ß-type subunits are found (40), which are, except for subunit 
Y13, all essential for life (13). However, in higher eukaryotes three extra genes coding for the 
ß-type subunits LMP7, LMP2 and MECL1 have been identified. These genes are γ-interfe-
ron-inducible and group together in a phylogenetic tree with the γ-interferon-downregulated 
ß-type subunit genes MB1/X, Delta/Y and Z, respectively (13,49). The γ-interferon- induci­
ble gene products replace their counterparts resulting in proteasomes with altered proteolytic 
activities, which probably have a function in the generation of antigenic peptides (reviewed 
in (20,49,50). Table 1 shows some characteristics and alternative names of the subunits of 
the human and yeast 20S proteasome. The new nomenclature based on the yeast crystal 
structure as proposed by Groll and coworkers (46) is also included. 
Two years ago the crystal structure of the proteasome of Thermoplasma acidophilum has been 
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14 Fig. 2. Schematic representation of the human 20S 
proteasome. The three dimensional representation (left) and 
rolled-off cylinder envelope show the subunit topology of the 
human particle, based upon the yeast crystal structure (46).The 
model of the human 20S proteasome proposed by Kopp and 
coworkers (45) differs in the position of four ß-type subunits: 
С ΙΟ-H and C5, and C7-I and MB I are switched. Abbreviations: 
HSB=HsBPROS26, 30=HsPROS30 and 27=HsPROS27. 
solved, which resulted in an enormous progress in our understanding of the proteasome 
structure and function (38). Notwithstanding that the a- and ß-subunits have only 26% 
sequence identity, the crystal structure revealed that both subunits have a very similar and 
novel fold. The core of the proteins is formed by two five-stranded antiparallel ß-sheets, 
which are flanked by three α-helixes on top and two at the bottom (38). The last three years 
several multimeric enzymes, which share no significant homology to proteasomal subunits, 
have been shown to contain the same folding pattern and catalytic mechanism (51). They 
were designated N-terminal-nucleophile (Ntn-) hydrolases (46) according to their putative 
catalytic mechanism (see below) which confers either amidohydrolase or amidotransferase 
activity (52). 
The crystal structure of the archaebacterial proteasome further revealed that the subunits 
within and between the rings are very closely packed, leaving no holes in the wall of the 
cylindrical structure. A small gate, 13 Â in diameter, at both ends of the particle is the only 
connection between the outside and the three inner cavities of the proteasome. Since the 
catalytic sites reside in the largest compartment in the center of the complex, the small 
openings are a physical barrier protecting cellular protein from uncontrolled degradation (see 
below). 
A second breakthrough in proteasome research is the very recent solution of the crystal 
structure of the yeast proteasome (46). It clearly shows that this proteasome consists of two 
identical halves, each containing 14 different subunits located at defined positions (Fig 2). 
The subsequent α, β, β, a-rings are each -10° out of register. The very recently constructed 
model of the subunit topology of the human 20S proteasome, based upon data obtained 
from chemical crosslinking and immuno-EM studies, differs in the position of 4 ß-type 
subunits (see legends of Fig.2 (45)). Since corresponding subunits from yeast and man are 
very similar (40-55% similarity (41)), it is unlikely that the human proteasome has an other 
subunit topology than the yeast particle. 
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Like the archaebacterial a- and ß-subunits, all yeast subunits have a ß-sandwich structure, at 
the top and bottom flanked by α-helixes, typical for Ntn-hydrolases (46,51). Differences 
between subunits appear in the length of turns, in long insertions connecting and/or exten­
ding structural elements, and in the N-terminal and especially the C-terminal regions. Many 
of these subunit-specific elements are involved in intersubunit contacts (46). 
The overall architecture of the yeast particle is very similar to the archaebacterial protease 
complex. The yeast proteasome is also a barrel-shaped complex containing three inner cavi­
ties, but it lacks the 13 A wide entry ports at the ends, as is present in the T. acidophilum 
particle. While the yeast α-discs seem firmly closed, there are some narrow openings present 
in the side wall at the interface between the a- and ß-rings of the complex. They have a 
diameter of about 10 Â, which may allow passage of unfolded, extended polypeptides. 
Probably binding of the 19S regulatory complex or the proteasome regulator PA28 to the 
particle poles, which both activate peptide hydrolysis ((53), reviewed in (20)), may cause a 
rearrangment in the α-rings and open the entry ports of the 20S proteasome (46). 
Proteolytic activity 
The first report on the multicatalytic properties of the proteasome stems from 1983 when 
Wilk and Orlowski distinguished three different proteolytic activities; "trypsin-like", "chymo-
trypsin-like" and "peptidylglutamyl-peptide hydrolase" activity (31). These three proteasomal 
activities refer to the peptide bond cleavage on the carboxyl side of basic, hydrophobic and 
acidic amino acid residues, respectively. They were identified using short synthetic peptide 
substrates and believed to be catalyzed at independent sites because the different proteolytic 
activities respond differently to various activators and inhibitors. Using similar approaches at 
least five different proteolytic activities were described ((54), reviews (55,56)). Contrary to 
the eukaryotic proteasome, which contains multiple proteolytic activities, the much simpler 
archaebacterial particle has only chymotrypsin-like activity (22). 
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16 The proteolytic mechanism was also long a matter of debate. Proteasomal subunits show no 
sequence homology to members of the four classical proteases; the serine, cysteine, aspartic 
acid or metallopcptidases (57). Studies with standard inhibitors revealed that the proteasome 
might be an unusual type of serine endopeptidase. However, unlike typical serine peptidases, 
it is insensitive to diisopropyl fluorophosphate and peptide chloromethyl ketones (reviewed 
in (55,56)). Major contributions to the understanding of the structure of the proteolytic 
center were the solution of the crystal structures of proteasomes from the archaebacterium 
T. acidophilum (38) and yeast (46), and the mutational analysis of their subunits (58-60). 
By mutagenesis studies it was found that neither serine nor histidine residues (the ß-subunit 
does not contain cysteine) are essential for the activity of the T. acidophilum enzyme (58). 
Several lines of evidence demonstrate that the hydroxyl group of the threonine residue (Thr1, 
see Fig. 3) at the N-terminus is the active-site nucleophile: (1) Replacement of Thr1 by an 
alanine residue abolished the proteolytic activity, suggesting that this threonine residue is 
near or in the catalytic center (59). (2) Mutation of this threonine to serine, which contains a 
similar side chain, does not impair proteolytic activity (59); (3) In the crystal structures, the 
hydroxyl group of this threonine is in close proximity or bound to the aldehyde group of the 
proteasome inhibitor ./V-acetyl-Leu-Leu-nor-leucinal (38,46); (4) Lactacystin, which is a 
natural covalent inhibitor of eukaryotic proteasomes, binds to the N-terminal threonine of 
subunit MB1/X (61); (5) The Thr1 residue is conserved in all bacterial ß-subunits and in 6 
out of 10 mature human ß-type subunits (Fig. 3, (59)). Besides a nucleophile, a basic group 
is essential to catalyze peptide bond hydrolysis. The two most likely proton acceptors/donors 
are the free α-amino group of Thr 1 and the side chain amino group of the lysine residue at 
position 33 of the mature subunit (Lys33). Both are conserved in the potentially active ß-type 
subunits and in close proximity to the active site. Furthermore, mutation of Lys33 in the 
T. acidophilum ß-subunit impaired proteolysis (59). The fact that not all ß-type subunits have 
the Thr1 residue indicates that not all these subunits are proteolytically active. Potentially 
active are the three γ-interferon-inducible subunits and their constitutive counterparts. 
Mature HsBPROS26 is probably inactive despite its N-terminal threonine (Fig. 3), since this 
subunit has an extended N-terminus compared to the active subunits and lacks other 
conserved amino acid residues near the catalytic center {e.g. Lys33) (59). The crystal structure 
of yeast proteasomes saturated with the peptide-aldehyde inhibitor revealed that indeed only 
the three subunits with a threonine residue at the N-terminus, PUP1/Z, PRE3/Delta and 
PRE2/MB1, bind the inhibitor. From the size and charge distribution of each peptide 
binding pocket it has been suggested that subunit PRE2/MB1 may confer trypsin-likc and 
chymotrypsin-like activity, that PRE3/Delta is essential for PGPH activity and that Pupl/Z 
may cleave after large amino acid residues (46). This active site assignment is in line with 
previous mutagenesis (60,62-64) and inhibitor studies (26). From the crystallographic 
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T. acidophilum 
β MNQTLETGT TTVG 
R. erythropolis 17 
ßl MTADRPALRTGDRDTRLSFGSNLSSFTDYLRGHAPELLPENRIGHRSHSTRGGDGMESGDLAPHGTiTIVA 
ß2 MTVDR-APRITDGDTRLSFGSNLSSFSEYLRVHAPEHLPQNRFADT GGWMGGGDVAPHGl TI VA 
human 
MBI/X . . .PEEPGIEMLHGT TTLA 
LMP7 MALLDVCGAPRGQRPESALPVAGSGRRSDPGHYSFSMRSPELALPRGMQPTEFFQSLGGDGERNVQIEMAHGT.TTLA 
HsDelta/Y MAATLLAARGAGPAPAWGPEAFTPDWESREVSTGn'IMA 
LMP2 MLRAGAPTGDLPRAGEVHTGÎ'TIMA 
Ζ MAAVSVYAPPVGGFSFDNCRRNAVLEADFAKRGYKLPItVRKTGÏ TIAG 
MECLl MLKPALEPRGGFSFENCQRNASLERVLP--GLKVPHARKTG1'TJ:AG 
HsBPROS26 MEAFLGSRSGLWAGGPAPGQFYRIPSTPDSFMDPASALYRGPITRIQNPMVTGTSVLG 
HsC5 MLSSTAMYSAPGRDLGMEPHRAAGPLQLEFSPYVFNGGTILA 
HsC7-I MEYLIG 
HsC10-II MSIKSYNGCAVMA 
Fig. 3. N-terminal amino acid sequences of bacterial and human ß-type subunits. The 
aligned N-terminal ß-type subunit sequences are obtained from Lupas et al. (79). Prosequences are 
depicted in bold, the mature sequences in regular font and the N-terminal amino acid of the ma-
ture protein is underlined.!"1 is the conserved Thr', which is most likely acting as the nucleophile 
in the proteolysis reaction. 
structure of the yeast proteasome a potentially new type of active center has been postulated, 
which is formed by 3 to 4 main chain carbonyl oxygens at the ends of helix H2 of all seven 
subunits together with some water molecules (46). 
The contribution of each individual proteolytic activity, assayed with short testpeptides, to 
the degradation of longer peptides and complete proteins is unknown. Analysis of degrada-
tion products revealed that the archaebacterial proteasome, which seemed only to have 
chymotrypsin-like activity, can cleave after most amino acids. This indicates that the 20S 
proteasome is in fact a non-specific endopeptidase (65). However, the peptides generated fell 
into a rather narrow size range of 6 to 10 amino acids, indicating the existence of some kind 
of "molecular ruler" (65). The medium length of seven to eight amino acids of the 
degradation products is in agreement with the distance between the active sites of the 
archaebacterial proteasome (38). A similar non-specific endopeptidase activity and size 
distribution of degration products from whole proteins was observed for eukaryotic 
proteasomes (66-69). 
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tion by the 20S protcasome in vitro (56,70). Denaturation of the substrate protein by 
oxidation (71) or reduction of disulphide bridges (72) can render it accessible to degradation 
by proteasomes. Also small gold particles with a diameter of 2 nm cannot enter the 
proteasome (72). These results suggest that a relatively narrow opening controls access to the 
inner proteolytic compartment of the proteasome. This hypothesis was confirmed by the 
crystal structures of the archaebacterial and yeast proteasome, which show that the only 
openings in the archaebacterial proteasome are two 13 Â-wide holes surrounded by hydro-
phobic amino acid residues in the center of the α-rings at each side (38), and the yeast 
proteasome has only some side openings (46). Such a size exclusion mechanism implies that 
energy-dependent unfolding of substrates is essential for proteolysis by the proteasome. In 
eukaryotes this and probably also opening of the α-rings might be a function of the various 
ATPases which are components of the 19S regulatory complex. 20S proteasomes may also act 
in cooperation with molecular chapcrones capable of recognizing and stabilizing unfolded 
polypeptides (72,73). 
Assembly 
Throughout evolution the number of different proteins contributing to the 20S proteasome 
complex has increased: the 20S proteasome of the archaebacteria T. acidophilum and 
Methanosarcina thermophila consists of one a- and one ß-subunit (22,74), two α-type and 
two ß-type subunits form the complex of the eubacterial actinomycete Rhodococcus sp. (23) 
and the eukaryotic 20S proteasomes embodies seven different α-type and seven different 
ß-type subunits. In higher eukaryotes there is a further diversification of the ß-type subunits. 
Yeast contains seven genes encoding ß-type subunits (40), whereas mammals have ten ß-type 
subunit encoding genes (see above, (49)). Hence, the assembly mechanisms are more 
complex in higher order species. Major knowledge is available about the assembly of the 
archaebacterial 20S proteasome. Expression of the T. acidophilum a- (Та-a) and ß-subunit 
(Ta-ß) in Escherichia coli resulted in fully assembled and functional proteasome complexes 
(75). The prosequence of Ta-ß is dispensable for correct assembly. Separate expression of 
Ta-α resulted in the formation of double seven-membered α-rings, whereas Ta-ß alone was 
monomeric and its prosequence was not cleaved off (76). Therefore, in T. acidophilum the 
formation of α-rings is most likely the first step in proteasome assembly, and subsequently, 
α-rings function as a matrix, which chaperones the folding, assembly and proteolytic 
processing of the ß-subunits (76,77). The 35 amino acid residues at the N-terminus of the 
a-subunit, lacking in the ß-subunit, are important for assembly (76). Amino acids 21-32 
form an α-helix (HO) which indeed contacts the HO-preceding loop of the neighboring 
a-subunit in rings (38). 
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Proteolytic processing of the inactive precursor to activate the protein has been suggested to 19 
proceed by an intramolecular mechanism in all Ntn-hydrolases (51) In vitro denaturation/ 
reconstitution experiments with purified Ta-α and precursor-Ta-ß resulted in processing of 
the ß-subunit, showing that proteolytic Ta-ß processing is indeed autocatalytic Both pro-
cessed and unprocessed Ta-ß were efficiently incorporated into proteasome particles Since no 
processed Ta-ß remained unassembled, in vitro processing appears to be connected to 
assembly (77) In vivo, only active Ta-ß mutants were processed indicating that the residues 
important for protease activity are also essential for processing One exception was a Ta-ß-
ThrlCys mutant, which is efficiently processed but proteolytically inactive, indicating that 
the geometry of the active sites for processing and catalysis in the mature complex is slightly 
different (77) Furthermore, Seemuller and coworkers (77) showed that the autocatalytic 
processing pathway of the ß-subunits of Τ acidophilum can occur via intramolecular and 
intermolecular cleavages 
The recently discovered eubactenal proteasome from the actinomycete Rhodococcus 
erythropohs strain N186/21 seems to consist of two different α-type and two ß-type subunits 
(23) The number of subunits in α-ring and subunit stoichiometry has not yet been deter­
mined However, recombinant expression of all four combinations of one α-type and one 
ß-type subunit yielded fully assembled and proteolytically active native-like particles 1 he 
most likely topology of the native particle is that the a- and ß-nngs have a random subunit 
distribution (78,79) 
Like Τ acidophilum inactive ß-type precursors of Rhodococcus are proteolytically activated 
only in the presence of an α-type subunit Contrary to the Ta-α, which assembles into seven-
membered rings, the two α-type subunits of Rhodococcus cannot assemble into ring com­
plexes upon separate or coexpression (79) This may indicate that initial formation of a 
complete α-ring is not essential for proteasome assembly 
Up to now, the assembly of the complex eukaryotic proteasome is not well understood but 
must be a coordinated process, since each of the 14 different subunits resides at a fixed posi­
tion (see above) Especially early steps in the assembly pathway are not known The current 
assembly model of eukaryotic proteasomes is in part extrapolated from the assembly pathway 
of Τ acidophilum., which starts with the formation of an α-ring However, no such comple­
xes, containing all a- but no ß-type subunits, have been isolated or reconstituted m vitro yet 
Several groups have identified complexes of 13-16S containing most of the a- and several ß-
type subunits (80-83) The 13S assembly intermediates are possibly half-proteasomes which 
upon dimenzation form 16S complexes (83) Finally, these complexes are converted into 
mature proteasomes Completion of the maturation proces was inhibited by cyclohexamide 
(80,82) and did not occur in purified 16S complexes (83), suggesting that additional factors 
are necessary for the assembly proces Interestingly, the chaperonin Hsc73 was found to be 
C H A P T E R I 
20 associated to the 16S complexes (83,84). This chaperone is possibly involved in keeping the 
ß-type subunits at the interface of two half-proteasomes in the proper conformation to 
enable maturation processes to occur. 
An important maturation event to activate the proteasome is the proteolytic processing of 
some ß-type subunits (Fig. 3). Apparently, this is a late assembly event, since the proteoly-
tically inactive 13-16S complexes contain some pro-ß-subunits, whereas the active 20S 
proteasomes only contain mature ß-type subunits (80,85). Very recently it has been shown 
that prosubunit processing of LMP2 and Delta/Y takes place in the 16S precursors and not 
in the 13S complexes (83). Furthermore, correct processing seems to require proper interac-
tion of two half proteasomes (60). For efficient processing of ß-type subunits and integration 
in proteasomes of eukaryotes, an intact and correct propeptide is essential. The propeptide 
most likely prevents preliminary activation of the ß-type subunits and in some cases can act 
as an intramolecular chaperone, important for correct folding of a subunit (60). A similar 
function for prosequences of various other proteases has been reported (86). Whether this 
property is common to all proteasomal propeptides is not clear. Exchange of the prosequence 
of LMP2 with the propeptide of LMP7 (P7LMP2) resulted in partially processed chimeric 
ß-type subunits. These polypeptides, albeit with low efficiency, were correctly incorporated 
into the proteasome particle, indicating that the prosequence probably is not involved in the 
correct positioning (84,85). 
Several mutated pro-ß-subunits are partially processed resulting in eight to ten amino acids 
longer proteins (85). Interestingly, three of the predicted inactive human ß-type subunits also 
contain N-terminal extensions of seven to nine amino acids (Fig. 3, (59,87)). Probably, 
ß-type subunit processing is a two-step mechanism: at first the propeptide is trimmed into 
seven to ten amino acid residues and active subunits are subsequently cleaved at the 
consensus site (prior to Thr1) (84,85). 
G E N E R A L I N T R O D U C T I O N 
Outline of thesis 21 
In this thesis we describe a study of the structure, assembly (chapter 2, 3 and 4) and 
functions (chapter 5) of the 20S proteasome. To learn more of proteasome structure and 
assembly we studied five different recombinant human subunits. In chapter 2 cloning of a 
cDNA encoding the human ß-type subunit HsBPROS26 is described. Recombinant 
expression of this subunit yielded a soluble, monomeric and proteolytically inactive protein. 
Zwickl and coworkers (76,75) obtained a similar result with the ß-type subunit of 
T. acidophilum. 
In Chapter 3 we describe the properties of the recombinant human α-type subunit HsC8. 
Like the Та-a-subunit this human α-type subunit also forms ringlike structures by itself. 
Using image analysis we clearly demonstrate that the HsC8 complexes consist of two 
parallelly oriented rings, each containing seven subunits. We also investigated whether simple 
proteasome-like complexes could be made from human subunits. Therefore, we coexpressed 
HsC8 and HsBPROS26, HsBPROS26
m a t or a mature-like Delta subunit. However, we could 
not obtain functional proteasome-like complexes upon coexpression of HsC8 with either 
ß-type subunit (chapter 3). 
In chapter 4 we show that ring formation is not a general feature of human α-type subunits. 
Expression of the human α-type subunits HsPROS30 or HsPROS27 yielded dimers. 
However, upon coexpression with HsC8, both a-type subunits assemble into hetero-
oligomeric ring complexes. The composition of these ring complexes is surprisingly variable, 
which seems to be in contrast with the fixed position of each subunit in the proteasome. 
The implications of these findings for the eukaryotic proteasome assembly model is discussed 
(chapter 4). 
In chapter 5 we studied the function of proteasomes in the cell cycle progression using the 
proteasome inhibitor MG115 and several control peptide inhibitors, which display 
differentia] effects on proteasomal proteolytic activity. We showed that the inhibitor MG115 
and to a lesser extent calpain inhibitor I, block Gl-S and metaphase transition and delay 
progression through S-phase. This effect was reversible and its extent was proportional to the 
inhibition of proteasomal activity of the inhibitor in vitro. The function of proteasome-
mediated degradation of key components during different stages of the cell cycle is discussed 
(chapter 5). 
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Cloning and expression 
of a human proteasome 
ß-subunit cDNA 
A homologue of the yeast PRE4-
subunit essential for peptidylglutamyl-
peptide hydrolase activity. 
C H A P T E R 
Abstract 
The cDNA encoding the human proteasome ß-subunit (HsBPROS26) was isolated from a 
lymphoma library using the cDNA of the Xenopus homologue as a probe. The cDNA 
contains an open reading frame encoding a protein of 233 amino acids and a calculated 
molecular mass of 25,909. Comparison with interspecies homologues of HsBPROS26 from 
Xenopus (XLB), rat (RN3) and yeast (PRE4) reveals a high degree of identity between the 
ß-subunits except for the N-terminal end, which is probably cleaved post-translationally. 
The complete coding sequence of HsBPROS26 has been expressed in E. coli. The produced 
protein of about 27 kDa reacts with the proteasomal monoclonal antibody MCP205, kindly 
provided by Dr. K. Hendil. The molecular mass of the native protein is about 28 kDa 
indicating that the protein is present as monomers. Finally partially purified HsBPROS26 
preparations do not contain any proteolytic activity. 
2 
C H A P T E R 1 
30 Introduction 
Protcasomes are ubiquitous, cylindrical multicatalytic proteinase complexes with a molecular 
mass of 720 kDa consisting of 15-25 different subunits. These complexes, which are found 
in all eukaryotic cells analyzed to date, are thought to be important in non-lysosomal protein 
breakdown [1-2]. In some Archaebacteria a comparable particle is present containing only 
two different subunits named α and β [3]. cDNA cloning and analysis of several eukaryotic 
subunits revealed that they can be subdivided into two related families of α-type and ß-type 
respectively, according to the homology with the archaebacterial a- or ß-subunit [4,4а]. 
Between different eukaryotes very homologous subunits of over 95% sequence identity were 
found [5]. For higher eukaryotic proteasomes little detailed information is available on the 
properties of single subunits, which could give information on subunit-subunit interaction 
and thus assembly and subunit composition of the particle. Expression of cDNAs in E. coli 
[6] is a way to produce large amounts of proteasome subunits. The a- and ß-subunits of 
Thermoplasma acidophilum were readily synthesized in E. coli and simultaneous expression of 
both subunits resulted in the formation of functional proteasomes [7]. 
Here we report the cloning and expression in E. colt of the human ß-subunit (HsBPROS26) 
cDNA in order to enable the study of the properties of this subunit in more detail. 
Materials and methods 
Screening procedure and analysis of the HsBPROS26 cDNA 
A lymphoma cDNA library in the λΖΑΡ (Stratagene) was screened by Southern hybridi­
zation at 60°C with the complete Xenopus laevis ß-subunit (XLB) cDNA [8] as a probe. 
Recombinant pBluescript SK- phagemids were rescued from positive bacteriophage clones by 
in vivo excision according to the procedure provided by the manufacturer. 5'-Ends of the 
cDNA's in this vector were sequenced using single-stranded DNA and the KiloBase Sequen-
cing System (Biorad; Fig. 1, hatched arrows). The longest HsBPROS26 clone (number 17) 
was completely sequenced (Fig. 1, filled arrows) using double-stranded DNA and Sequenase 
(United States Biochemical). Blotting procedures, radiolabeling of probes and subcloning 
were performed using standard methods [9]. Homology searches and characterization of the 
open reading frame were performed with the CAOS/CAMM computer facility of the 
University of Nijmegen, which includes Fasta, Clustal V, Motifs and Pepstats [10]. 
Expression of the HsBPROS26 protein 
The HsBPROS26 cDNA was expressed in the pET expression system of Studier et al. [6]. 
To subclone the complete open reading frame of the HsBPROS26 properly in the рЕТЗс 
expression vector we mutated the ATG startcodon to generate a NdA restriction site. This 
was achieved by site-directed mutagenesis using the oligonucleotide-directed in vitro 
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mutagenesis system (Amersham) and the mutagenic primer (Eutogentec): 31 
5'-CTCCCGATTCCTCCATGGATCCGGC-3' 
NM 
The mutated Ndel-Xhol HsBPROS26 cDNA fragment was cloned into the NM-BamHl 
sites of the рЕТЗс vector and transformed to E.coli BL21(DE3). For production of the 
HsBPROS26 protein, bacteria were grown in LB medium containing 100 pg/ml ampicillin. 
At Л«,) 0.6 expression was induced by adding IPTG to a final concentration of 1 mM. 
Bacteria were harvested 4 h after induction by centrifugation at 5,000 X g for 20 min. After 
resuspension of the pellet in lysis buffer (50 mM Tris/HCl, pH 7.6, 1 mM EDTA, 0.3 mM 
NaCl) bacteria were lysed with chicken egg white lysozyme (Sigma). The water-soluble 
fraction (WSF) containing most of the HsBPROS26 protein was obtained after centrifuga­
tion at 10,000 Xgfor 30 min. Expression of the HsBPROS26 protein was analyzed by SDS-
PAGE and Western blot. The molecular mass of the native HsBPROS26 protein present in 
the bacterial WSF was determined using HPLC gel filtration on a Superdex 75 column 
(Pharmacia). Proteolytic activity of the HPLC-sample containing HsBPROS26 (1 pg) was 
determined with the fluorogenic peptides Cbz-LLE-NA, benzoyl-FVR-MNA and succinyl-
LLVY-AMC according to [11]. 
Results and discussion 
The screening of I.106 plaques with the XLB cDNA resulted in the isolation of 24 clear pos­
itives including 14 clones containing HsBPROS26 cDNAs of different lengths. Partial 5'-se-
quences of these cDNAs and the total sequence of clone 17, which containcs the complete 
coding sequence, were obtained. The overall homology of XLB and HsBPROS26 cDNAs 
turned out to be 66%. The HsBPROS26 nucleotide sequence and the deduced amino acid 
sequence are shown in Fig. 1. The nucleotide at position -19 is variable, in two of three 
clones analyzed a guanidine and in one an adenosine was found. A partial sequence in the 
EMBL-EST database encoding the 5'-end of HsBPROS26 (EM_EST:T08798) [12], iden­
tical to the 5'-end of our clone, also has an adenosine at that position. This polymorfism 
reflects most likely the existence of two functionally identical HsBPROS26 alleles. The open 
reading frame of 233 amino acids encodes a protein with a molecular mass of 26 kDa (hence 
the indication HsBPROS26) and a pi of 5.8. The putative product contains only the 
consensus sequence for the family of proteasomal ß-type subunits, defined in the Motifs 
program, and the N-terminal sequence of the human ß-subunit determined by direct protein 
sequencing [13]. This suggests that the N-terminal part of the primary product is cleaved 
resulting in a mature protein containing 219 amino acids, with a molecular mass of 24,5 
kDa and a pi of 5.4. Post translational cleavage of the N-terminus also occurs in the rat 
32 
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it 
SphI 
gaattcggcacgaggttttt -80 
ggggtcgcggtccggactttgggcggggggtccggccccaggacagtttLaccgcattccgtccactcccgattccttc - 1 
atg gat ccg gcg tct gca ctt tac aga ggt cca ate acg egg ace cag aac ccc atg gtg 60 
MET Asp Pro Ala Ser Ala Leu Tyr Arg Gly Pro H e Thr Arg Thr Gin Asn Pro MET Val 20 
ace ggg ace tea gtc etc ggc gtt aag ttc gag ggc gga gtg gtg att gec gca gac atg 120 
Thr Gly Thr Ser Val Leu Gly Val Lys ?he Glu Gly Gly Val Val Ile Ala Ala Asp MET 40 
ctg gga tec tac ggc tec ttg get egt ttc cgc aac ate tct cgc att atg cga gtc aac 180 
Leu Gly Ser Tyr Gly Ser Leu Ala Arg Phe Arg Asn H e Ser Arg H e MET Arg Val Asn 60 
aac agt асе atg ctg ggt gee tct ggc gac tac get gat ttc cag tat ttg aag caá gtt 240 
Asn Ser Thr MET Leu Gly Ala Ser Gly Asp Tyr Ala Asp Phe Gir. Tyr Leu Lys Gin Val 80 
etc ggc cag atg gtg att gat gag gag ctt ctg gga gat gga cac age tat agt cet aga 300 
Leu Gly Gin MET Val H e Asp Glu Glu Leu Leu Gly Asp Gly His Ser Tyr Ser Pro Arg 100 
get att cat tea tgg ctg ace agg gee atg tac age egg cgc teg aag atg aac cet ttg 360 
Ala H e His Ser Trp Leu Thr Arg Ala MET Tyr Ser Arg Arg Ser Lys MET Asn Pro Leu 120 
tgg aac ace atg gtc ate gga ggc tat get gat gga gag age ttc etc ggt tat gtg gac 420 
Trp Asn Thr MET Val H e Gly Gly Tyr Ala Asp Gly Glu Ser Phe Leu Gly Tyr Val Asp 140 
atg ctt ggt gta gec tat gaa gec cet teg ctg gee act ggt tat ggt gca tac ttg get 480 
MET Leu Gly Val Ala Tyr Glu Ala Pro Ser Leu Ala Thr Gly Tyr Gly Ala Tyr Leu Ala 160 
cag cet ctg ctg cga gaa gtt ctg gag aag cag cca gtg eta age cag ace gag gee cgc 540 
Gin Pro Leu Leu Arg Glu Val Leu Glu Lys Gir. Pro Val Leu Ser Gin Thr Glu Ala Arg 180 
gac tta gtc aga caa cgc tgc atg cga gtg ctg tac tac cga gat gec egt tct tac aac 600 
Asp Leu Val Arg Gin Arg Cys MET Arg Val Leu Tyr Tyr Arg Asp Ala Arg Ser Tyr Asn 200 
egg ttt caa ace gee act gtc асе gaa aaa ggt gtt gaa ata gag gga cca ttg tct аса 660 
Arg Phe Gin Thr Ala Thr Val Thr Glu Lys Gly Val Glu Ile Glu Gly Pro Leu Ser Thr 220 
gag acc aac tgg gat att gec cae atg atc agt ggc ttt gaa tga aatacagatgcattatcca 724 
Glu Thr Asn Trp Asp Ile Ala His MET Ile Ser Gly Phe Glu *** 234 
gaactgaagttgccctacttttaacttlgaacttggctagttcaaagatagactcttcttttgtaaagtaaataaattc 803 
t tcaaaa tgaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaac tegag 863 
Fig. I. Nucleotide sequence and predicted amino acid sequence of H s B P R O S 2 6 (lower 
panel). Underlined is the amino acid sequence of HsBPROS26 obtained by direct protein sequen­
cing [13]. Double underlined is the consensus sequence for ß-type proteasome subunits.The 
putative signal for polyadenylation (AATAAA) is overlined.The upper panel shows the sequence 
strategy and restricion sites used herein. Numbers indicate the start and stop nucleotide of the 
coding region (box). Hatched and filled arrows indicate 5'-sequenced regions of different clones 
and sequenced regions of clone 17, respectively. 
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homologue of HsBPROS26, RN3 [14], ß-subunit of Thermopksma [7] and probably most 33 
ß-type subunits. Northern blot analysis of poIy(A)* RNA derived from human melanoma cell 
lines 530 and M14 [15] using the HsBPROS26 cDNA as a probe revealed one single band 
of about 1.04 kb indicating that HsBPROS26 clone 17 is nearly full length (not shown). 
Homology searches in the EMBL nucleotide sequence database resulted in the identification 
of the partial sequence Mmorfa (M74556), most likely of the mouse homologue of 
HsBPROS26. This cDNA sequence of 166 nucleotides shows 88.6% identity to nucleotide 
78-243 of HsBPROS26. The authors assign the start of the coding sequence to nucleotide 
111. However, upon our deduction of the amino acid sequence, starting at nucleotide 2 of 
Mmorfa and applying 2 insertions (Fig. 2, positions 81 and 90) we found at least 89% 
identity and 96% similarity with HsBPROS26. In view of this very high homology we 
A 
80 90 100 110 120 130 140 
HSB CGGCGTTAAGTTCGAGGGCGGAGTGGTGATTGCCGCAGACATGCTGGGATCCTACGGCTCCTTCGCTCGT 
l>l Ι ι 1111,11! ! Ι Ι Ι Η ι Ι ι I : I I I I I I I , I I I I I I Ι ι I I I I I I ! I , II I .I Ι Μ ι I I I! 
Mmorfa CGGGGTGAAGTTCGACGGCGGAGTGGTGATTGCTGCAGACATCGTGGGCTCCTACGGCTCCCTGGC7CGT 
'.О 20 30 40 50 60 70 
150 160 170 180 190 20C 210 
HSB TTCCGCAACATCTCTCGCATTATGCGAGTCAACAACAGTACCATGCTGGGTGCCTCTGGCGACTACGCTG 
I I I I I I I I M I I Γ I 1 I 4 I I I I I < I I I I I M I I I I I I I I I I I I I I I I I 
Mmor fa TTCCGCAATA. CTCTCGTA. TATGCGAGTGAACGACAGCACTATGCTGGGTGCCTCGGGAGACTACGCTG 
80 90 100 110 120 130 140 
220 230 240 
HSB ATTTCCAGTATTTCAAGCAAGTTCTCGGCC 
I I I I I I I I I I I I I I I I I I I I I I I I I 
Mmorfa ATT7CCAGTATTTGAAACAAGTTCTC 
150 160 
В 
30 40 50 60 70 80 90 
HSB TGTSVLGVKFEGGWIAADMLGSYGSLARFRNISRIMRVNNSTMLGASGDYADFQYLKOVLGQKVIDEEL, 
1111:1 I I I I : : I I I III I I II 1111:1111 I I I I I I I I I Ι ι I I I 
MMORFA GVKFDGGWIAADIVGSYGSLARFRNxSRxMRVNDSTMLGASGDYADFQYLKQVL 
10 20 30 40 50 
Fig. 2. Alignment of the nucleic acid (A) and amino 
acid (B) sequence of HsBPROS26 and Mmorfa. 
The amino acid sequence was deduced from the nucleic acid 
sequence starting at position 2.The two codons containing the 
gaps (.), introduced in the nucleic acid sequence to obtain 
maximal homology, are translated as "x". 
C H A P T E R 1 
34 assume that two nucleotides at positions 81 and 90 in the published sequence are missing 
(Fig. 2). Our evaluation shows that the complete sequence of the fragment (166 nt and not 
55 nt) is coding for part of the mouse homologue of HsBPROS26. 
In a phylogenetic tree, based on the Clustal V multiple alignment of all available proteasomal 
amino acid sequences in the PIR and SWISSPROT databases, HsBPROS26, RN3, XLB and 
yeast PRE4 [16] formed a separate subbranch within the ß-subunit branch, indicating that 
they are interspecies homologues (not shown). Interestingly it has been reported that the 
yeast PRE4 subunit is essential for PGPH activity [16]. Multiple alignment of the four 
sequences (Fig. 3) clearly reveals the high degree of conservation between this type of subunit 
of different species, which has also been shown for other subunits [5,17]. RN3, XLB and 
PRE4 are, respectively, 93%, 8 1 % and 45% identical to HsBPROS26. The leader is not 
conserved in sequence and length, e.g. XLB seems to have no leader at all, suggesting that 
this track is not important for assembly or any other function. The sequence surrounding the 
potential nuclear targeting signal RRxK, as proposed previously [16] and which is conserved 
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1 2 0 1 3 0 
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R3KM 
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ISO 
UPLHNTMITIG 
IÏPLWNTK7IO 
« P L W N I W I G 
JPLWMIAIIVA 
190 
E3FL SYVDMLGVAY EAPSLATGYG 
EAPSLATGYG 
¡SAPÍTIIATGEH 
200 
AYLAQPLLRE VLEKQPVL3Q 
AYLAQPLLRE VLEK0PVL3Q! | 
AYLAQPLLRI^ vjrfe^KATksjC EÎAR. 
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E|RCM§VLYYR 
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2 2 0 2 3 0 2 « 0 2 5 0 2 6 0 
DARSYNRFdT I A T V . T E K G V E J J I E G P L S T ^ T T I UWDIAHMISG 
DARSYNRFflV ¡ATV.TEKGVE: | lEGPLSAgr. HWDIAHMISG 
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FE[... 
FE . . . . 
FEI . . . 
YGTQKI 
Fig. 3. Alignment of the amino acid sequences of 
HsBPROS26 homologues. Boxed residues are identical in at least 
two sequences. Gaps (.) have been introduced to obtain maximal 
homology. The potential nuclear targeting signal (RRxK) comprises 
amino acids 136-139. 
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Fig. 4. Expression of the HsBPROS26 
protein in E. coli. Lanes (1-5) Coomassie 
Brilliant Blue stained gel, lanes (6-10) 
¡mmunoblot of the same samples with 
MCP205. Lanes ( I ) and (6), total E coli 
BL21 (DE3) without expression vector, 4 h 
after induction with IPTG; lanes (2) and (7), 
total E. coli BL2I (DE3) containing the 
HsBPROS26 expression vector, just before 
induction and lanes (3) and (8) 4 h after 
induction; lanes (4) and (9),WSF of bacteria of 
lanes 3 and 8; lanes (5) and (10), purified calf 
liver proteasomes. SDS-PAGE molecular mass 
markers are indicated in kDa. 
35 
in yeast and Xenopus is also highly conserved in rat and human (Fig. 3), but the functionality 
hereof remains to be established. 
The pET expression system turned out to be a good system for high level expression of 
HsBPROS26. Fig. 4 shows that, after induction with IPTG, bacteria containing the 
HsBPROS26 expression vector for 4 h, the HsBPROS26 protein is expressed at higher levels 
than the bacterial proteins (lane 3). Western blot analysis was performed with the mono-
clonal antibody MCP205 that reacts with the human equivalent of rat RN3 (Kristensen 
et al, in preparation). Fig. 4 shows that only in bacteria with the HsBPROS26 cDNA 
yielded staining of a 27 kDa band (lane 7, 8 and 9). This correlates well with calculated 
molecular mass of the primary HsBPROS26 protein. In a purified liver proteasome 
preparation MCP205 reacts with a protein of approximately 25 kDa (lane 10), most likely 
representing the processed calf homologue of HsBPROS26. However, we do not know the 
identity of the reacting protein of about 57 kDa (lanes 3 and 4). 
Most of the HsBPROS26 protein was water-soluble. To determine the molecular mass of 
native HsBPROS26 we applied bacterial WSF on a Superdex 75 gel filtration column. All 
HsBPROS26 protein eluted just before chymotrypsinogen A (25 kDa), indicating that it is 
C H A P T E R 2 
36 present as monomers. This suggests that in the proteasome complex one HsBPROS26 sub-
unit is not associated to another one of the same type or that such an association is prevented 
by the leader sequence. The HPLC fraction containing the partially purified HsBPROS26 
protein was tested for proteolytic activity using the testpeptides Cbz-LLE-NA, benzoyl-FVR-
MNA and succinyl-LLVY-AMC. No activity towards these peptides could be detected. This 
is in agreement with the findings that dissociated proteasome particles no longer contain 
proteolytic activity [1,18,19]. 
Abbreviations 
PGPH, peptidylglutamyl-peptide hydrolase, HsBPROS26, Homo sapiens proteasome ß-
subunit, Cbz, benzoyloxycarbonyl, NA, ß-naphtylamide, MNA, 4-methoxy-ß-naphtylamide, 
AMC, 7-amido-4-methylcoumarin. 
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The human a-type 
proteasomal subunit HsC8 forms 
a double ringlike structure 
HsC8 does not assemble into 
proteasome-like particles with 
the ß-type subunits HsDelta 
or HsBPROS26 
Summary 
The eukaryotic proteasome is a barrel-shaped protease complex made up of four seven-
membered rings of which the outer and inner rings may contain up to seven different a- and 
ß-type subunits, respectively. The assembly of the eukaryotic proteasome is not well 
understood. We cloned the cDNA for HsC8, which is one of the seven known human 
α-type subunits, and produced the protein in Escherichia coli. Recombinant HsC8 protein 
forms a complex of about 540 kDa consisting of double ringlike structures, each ring 
containing seven subunits. Such a structure has not earlier been reported for any eukaryotic 
proteasome subunit, but is similar to the complex formed by the recombinant a-subunit of 
the archaebacterium Thermoplasma acidophilum (Zwickl, P., Kleinz, J., and Baumeister, W. 
(1994) Nature Struct. Biol. 1, 765-770). The ability of HsC8 to form α-rings suggests that 
these complexes may play an important role in the initiation of proteasome assembly in 
eukaryotes. To test this, we used two human ß-type subunits, HsBPROS26 and HsDelta. 
Both these ß-type subunits, either in the proprotein or in the mature form, exist in 
monomers upto tctramers. In contrast to the a- and ß-subunit of T. acidophilum, 
coexpression of the human ß-type subunits with HsC8 docs not result in the formation of 
proteasome-like particles, which would be in agreement with the notion that proteasome 
assembly in eukaryotes is much more complex than in archaebacteria. 
CHAPTER 3 
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40 Introduction 
The 20S proteasome is a multicatalytic protease complex which functions as the catalytic 
core of the larger 26S proteasome. This particle has been found in all eukaryotes analyzed to 
date and plays a major role in non-lysosomal proteolysis via the selective degradation of 
intracellular proteins, mostly by ubiquitin-dependent, but also ubiquitin-independent 
pathways (1-4). In the archaebacterium Thermoplasma acidophilum a particle is found with a 
similar quaternary structure, containing two different subunits named α and β (5). The 
complex consists of a stack of four rings, each containing seven subunits. The outer rings of 
the archaebacterial proteasome consist of a-subunits and the inner rings of ß-subunits, 
resulting in an 0.7^^70.7 complex (6,7). In eukaryotes several different proteasomal subunits 
are known which can be divided into two classes, α-type and ß-type, based on the similarity 
to either the a- or ß-subunit of Thermoplasma. (8,9). Seven different members of these 
a- and ß-type subunits may constitute, respectively, the heptameric a- and ß-rings of the 
eukaryotic proteasomes, each subunit residing possibly at a defined position (10-13). 
The 20S proteasomes degrade unfolded proteins (14) and oxidized proteins (15,16) in vitro. 
Degradation is achieved by at least 5 distinct catalytic activities which can be detected with 
chromogenic peptide substrates (17). Recently, the N-terminal threonine of the ß-subunit of 
T. acidophilum was identified as the catalytically active amino acid by X-ray crystallographic 
studies of inhibitor-proteasome complexes (7) and extensive mutational analysis (18). The 
N-terminal threonine results from proteolytic processing of the N-terminus, which is an 
essential step in the maturation of the proteasome. In eukaryotic proteasomes not all of the 
ß-type subunits may be proteolytically active (18). 
Little is known about the assembly of the eukaryotic proteasome particle. Several groups 
have identified 13S-16S particles containing most of the α-type subunits and some ß-type 
subunits in their unprocessed form (19-21). These so-called "preproteasomes" are converted 
into 20S proteasomes, a process which is translation-dependent and is accompanied by the 
proteolytic processing of the ß-type subunits. Expression of the T. acidophilum a-subunit in 
E. coli revealed that this subunit forms rings of seven subunits by itself, whereas the pro-ß-
subunit forms monomers (22). Coexpression of these subunits in E. coli resulted in the 
correct processing of the ß-subunits and subsequent formation of functional proteasomes 
(22,23). Recently, it was shown that the proteolytic processing of these ß-subunits is 
autocatalytic and that their folding and assembly is chaperoned by the a-subunits (24). 
To study whether similar processes occur during the formation of eukaryotic proteasomes we 
analyzed the assembly properties of the recombinant human proteasomal α-type subunit 
HsC8 (25). We found that upon expression in E.coli, HsC8 forms by itself large complexes 
consisting of pairs of heptameric rings, which closely resemble the recombinant α-rings of 
T. acidophilum. To test if simple proteasome-like complexes could be formed we coexpressed 
H s C B F O R M S D O U B L E R I N G S 
HsC8 with the ß-type subunit HsBPROS26 (26, also called HN3) or HsDelta (27, also 41 
called Y), but, in contrast to T. acidophilum proteasome assembly no such complexes could 
be isolated. 
Experimental procedures 
Cloning strategies 
Mutation and PCR primers were purchased from Eurogentcc. The Ncol and Ndel sites 
in the primer sequences are underlined. 
The pJG4-5HsC8 clone was selected via a yeast two-hybrid screening of a HeLa fusion 
cDNA library (28) with aB-crystallin (29) fused to LexA as the bait. The coding sequence of 
the HsC8 cDNA was amplified from the selected clone with PWO DNA polymerase 
(Boehringer) using the oligonucleotide 5'-ATCTGCCATGGGCTCAATCGGCACT-3', 
introducing an Ncol site containing the ATG-start codon and the oligonucleotide BcoII, 
consisting of a sequence located downstream of the polylinker of the pJG4-5 vector. The 
PCR product was digested with Ncol and Xhol and ligated into the Ncol-Xhol sites of the 
pET16b expression vector (pETl6bHsC8). For coexpression of HsC8 with ß-type 
proteasomal subunits the Xbal-BamWl fragment of pET16bHsC8 was subcloned into the 
Xbai-BamWl sites of pET24d expression vector (Novagen, pET24dHsC8). Both vectors 
encode the complete HsC8 protein with only a Ser to Gly mutation at position 2. 
Cloning of the HsBPROS26 cDNA and subcloning into рЕ'ГЗс (pET3cHsB) has been 
described elsewhere (26). Recently, also longer human (30, HsN3) and rat (31, RN3) 
BPROS26 cDNA clones have been isolated with a putative translation start 93 nucleotides 
upstream of the initiation codon of HsBPROS26. 
To construct the vector for expression of the mature protein (HsBPROS26
ma[) in bacteria, 
an Ndel site comprising a new ATG-start codon 39 base pairs downstream of the original 
start position the HsBPROS26 cDNA was generated by site-directed mutagenesis using the 
oligonucleotide-directed in vitro mutagenesis system (Amersham) with the oligonucleotide 
5'-CAGAGGTCCAATCÇArATGACCCAGAACCCC-3' as the mutagenic primer. 
The ЛШ-ХпоІ(Ыипг) fragment was then cloned into the №&I-.AzmHI(blunt) sites of 
рЕТЗс (pET3cHsB
mat). 
The HsDelta cDNA was cloned from a cDNA library of the human cell line MV3 (kindly 
provided by J. van Groningen, Nijmegen) using PCR with Taq polymerase. The primers 
were based on the reported cDNA sequence of human subunit Y (EMBL database accession 
no D29012) (27). The 5' primer used created also an Ndel site at the start codon: 
5'-AGAATTCAIATGGCGGCTACCTAACTAGCTGCT-3'. The 3' primer was: 
5'-TAGGATCCAGGATTCAGGCGGGTGGTAAGGT-3'. The amplified product was first 
ligated into the pCRII vector using a TA cloning kit (Invitrogen). The Ndel-BamHl 
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42 fragment was then subcloned into the Ndel-BamHl sites of рЕТЗс (pET3cHsD). Our 
HsDelta cDNA clone encodes an HsDelta protein which has a Gin to Arg mutation at 
amino acid position 41 of subunit Y, corresponding to position 7 in the mature protein (27). 
To produce the vector for expression of the mature HsDelta protein (HsDelta
ma[) part of the 
HsDelta cDNA in the pCRII vector was reamplified with PWO DNA polymerase using the 
5' oligonucleotide: 5'-AGAATTCATATGACCACTATCATGGCCGTGCAGTTT-3' and 
the HsDelta 3' oligonucleotide. The generated fragment contains a 5' Ndd site with the new 
ATG start codon 102 bp downstream the original start site. This fragment was cloned into 
the EcoRl-BamHl sites of pTZl8r. The Ndel-ВатШ fragment was subsequently subcloned 
into the Ndel-BamHl sites of рЕТЗс (pET3cHsD,
mt). Mutated cDNAs and cloned PCR 
fragments were analyzed by sequencing with the Sequenase version 2.0 sequencing kit 
(United States Biochemicals). A summary of the expression constructs and putative products 
is shown in Table I. 
Table I. Characteristics of proteasomal subunits studied.The type of the subunit reflects 
the homology with either the archaebactenal a- or ß-subunit. Molecular masses (kDa) were 
calculated with the Pepstats program of the CAOS/CAMM computer facility of the University of 
Nijmegen from the predicted amino acid sequence encoded by the expression constructs. 
subunit expression construct type Moleclar mass 
HsC8 
HsBPROS26 / HN3 
HsBPROS26mat/ HN3™ 
HsDelta/Y 
HsDelta™/Y™, 
pET 16bHsC8, pET24dHsC8 
pET3cHsB 
pETBcHsB™ 
pET3cHsD 
PET3CHSD™ 
a 
Ρ 
β 
Ρ 
Ρ 
28.5 
26 
24.5 
25 
22 
Single expression and coexpression of recombinant proteasomal proteins 
Single proteasomal subunits were expressed in the E. coli strain BL21(DE3) (32). Briefly, the 
pET-vectors were transformed to competent BL21(DE3) bacteria. A single colony of the 
transformation plate was grown at 37 °C in 1.5 ml LB (10 g/1 casein, enzymatic hydrolysate 
(Sigma), 5 g/1 yeast extract (Gibco-BRL), 10 g/1 NaCl) containing 200 mg/1 ampicillin 
(Sigma, рЕТЗс and pETlób) or 60 mg/1 kanamycin (Merck, pET24d) to an Л550 of 0.1 to 
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0.2. This culture was stored for maximally 20 h at 4°C or used directly to inoculate 50 ml or 43 
500 ml LB containing the appropriate antibiotics. At an Л550 of 0.5-1.0 expression of 
proteasomal proteins was induced by adding isopropyl-1-thio-ß-D-galactopyranoside (IPTG, 
Research Organics) to a final concentration of 1 mM. Bacteria were harvested 3 h after 
induction by centrifugation at 5000 χ g for 15 min. 
For coexpression host bacteria were cotransfected with pET24dHsC8 and а рЕТЗс construct 
containing a cDNA encoding a proteasomal ß-subunit. Bacteria containing both vectors were 
selected on LB plates containing ampicillin and kanamycin. The expression procedure was as 
described above except that all growth media contained ampicillin and kanamycin. 
Bacterial fractionation 
Bacterial pellets were resuspended in 1/25 volume of the culture volume in TEN300 (50 
mM Tris/HCl, pH 8.0, 0.5 mM EDTA, 300 mM NaCl) and frozen at -80°C. The bacteria 
were thawed at 37°C, lysed with chicken egg white lysozyme (Sigma) at 0°C and centrifuged 
for 30 min. at 90,000 X g at 4°C. The supernatant (water-soluble fraction) was used for 
determination of the molecular mass of the proteasomal ß-type subunits. 
HsC8 purification 
Recombinant HsC8 was purified from bacterial water-soluble fraction on a Sepharose Q Fast 
Flow column (Pharmacia). After loading the HsC8 extract, the column was washed with 
TEN300 and proteins were eluted with a linear gradient from 300 to 600 mM NaCl. HsC8 
emerged as almost pure protein (>95%) at about 550 mM NaCl. HsC8-containing fractions 
were pooled and concentrated in an Amicon ultrafiltration cell using a filter (Filtron) with a 
cutoff of 100 kDa. For electron microscopy (see below) HsC8 protein was further purified 
on a Superóse 6 HR 10/30 prepacked size exclusion column (Pharmacia-LKB) in 10 mM 
Tris/HCl, pH 7.5, followed by concentration of the HsC8 peak fractions in a microsep 
device (Filtron) with a cutoff of 100 kDa. 
Analytical procedures 
Analytical ultracentrifugation was performed on an Optima XLA analytical ultracentrifuge 
(Beekman Instruments) equipped with an ultraviolet absorption system (33). The 
concentration of the recombinant proteasome particles was adjusted to Am = 0.11, and the 
protein was analyzed at 20°C in 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA. 
Sedimentation velocity runs were performed at 52,000 rpm in a 12-mm double-sector Kel-F 
cell, which was filled with 0.12 ml of sample solution in one sector and the same volume of 
buffer measured at 230 η m in the other. Sedimentation coefficients were corrected to H2O 
by a standard procedure (34). Sedimentation equilibrium runs were performed at a rotor 
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speed of 4,400 rpm in an epon-charcoal 12-mm double-sector cell filled with 1.1 ml sample 
solution. The average molecular mass was determined using a linear regression computer 
program which adjusts the baseline absorption so as to obtain the best linear fit of InA versus 
r
1
 (A: absorption; r. radial distance from the rotor center). A partial specific volume of 
0.73 cm'/g was assumed. 
The molecular mass of the proteasomal subunits and subunit complexes present in bacterial 
water-soluble fraction was estimated by FPLC gel filtration in TEN300 on an LKB-Bromma 
HPLC system. Three different size exclusion columns were used to span a molecular mass 
range from 5 to 5000 kDa; Superóse 6 HR 10/30, Superóse 12 HR 10/30, and Superdex 75 
Hiload 16/60 (Pharmacia-LKB) with separation ranges of 50-5000 kDa, 5-300 kDa and 
5-70 kDa, respectively. Gel filtration columns were calibrated with marker proteins 
(Pharmacia-LKB) as indicated in the legends. Column fractions were analyzed by SDS-
PAGE (35) and either stained with Coomassie Brilliant Blue or blotted on nitrocellulose, 
whereafter the specific proteasomal subunits were detected with antibodies. Antibodies used 
are MCP72 (culture supernatant, diluted 1:50), directed against HsC8, MCP205 (ascites, 
diluted 1:2000) against HsBPROS26, and MCP421 (culture supernatant, diluted 1:50) 
against HsDelta (36,37), all three antibodies kindly provided by Dr. K. Hendil. Protein 
bands were visualized according to (38). 
The proteolytic activity of the subunits was tested with the synthetic peptide substrates Suc-
Leu-Leu-Val-Tyr-MCA (chymotrypsin-like), N-BZ-Phe-Val-Arg-MNA (trypsin-like) and N-
CBZ-Leu-Leu-Glu-ßNA (peptidylglutamyl-peptide hydrolase-like (PGPH-like)). The assays 
were performed in 200 μΐ reaction volume containing 20 μ% crude bacterial protein, 50 mM 
Tris/HCl pH 8, 150 mM NaCl, 0.1 mM EDTA, 1 mM DTE, 0.5% (v/v) DMSO and 
50 μΜ test peptide at 37°C. The reactions were stopped after 1 hour by adding 300 μΐ 1% 
(w/v) SDS and 700 μΐ 0.1 M sodium borate pH 9. Released fluorogenic groups were 
measured in a Hitachi F-3000 spectrofiuorometer at excitation and emission wavelengths 
respectively for MNA; 333 nm and 413 nm, for βΝΑ; 332 nm and 408 nm and for MCA; 
339 nm and 439 nm. 
N-terminal amino acid sequence analysis was performed at the Sequence Center of Utrecht, 
Institute of biomembranes, University of Utrecht. 
Electron microscopy and digital image processing 
Conventional transmission electron microscopy - For negative staining, a 5 μΐ aliquot of the 
HsC8 suspension diluted to about 25 pg/ml was adsorbed for 60 sec to a glow-discharged 
carbon-coated collodium film on a 400 mesh/inch copper grid. The grid was then washed 
sequentially on two drops of distilled water, stained for 15 sec with 0.75% uranyl formate, 
pH 4.25, and finally air-dried after removal of excess liquid with filter paper followed by 
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suction with capillary applied to the edge of the grid. Specimens were examined in a Hitachi 45 
H-8000 ТЕМ (Hitachi Ltd.) operated at 100 kV. Electron micrographs were recorded on 
Kodak SO 163 (Eastman Kodak Comp.) electron image film at a nominal magnification of 
52,000 x. Magnification calibration was performed according to Wrighly (39) using 
negatively stained catalase crystals. 
Mass analysis by quantitative Scanning Transmission Electron Microscopy (STEM) - for STEM 
mass determination of the HsC8 particles, a vacuum Generators (East Grinstead) HB-5 
STEM interfaced to a modular computer system (Tietz Video and Image Processing System 
GmbH) was employed (40). For this purpose, a 5 μΐ drop of the HsC8 suspension diluted 
to about 25 p-g/ml was adsorbed for 60 sec to a thin (i.e., 2.5 nm) hydrophilic carbon film 
which was supported by a thick fenestrated carbon film mounted on a gold-coated 
200 mesh/inch copper grid. Without negative staining, the grids were then washed 
sequentially on four drops of quartz bi-distilled water with a blotting step between each 
wash. Finally, the specimens were freeze-dried in the STEM's pre-treatment chamber at -
80°C overnight. Low dose (i.e., ranging from 300 c7nm2 to 1000 e/nm2), 512x512-pixel 
elastic annular darkfield images were recorded at 80 kV and a magnification corresponding 
to a sampling distance of 0.92 nm in the specimen plane. All microscope parameters, 
including the exact magnification and dose for each image, were recorded. Evaluation of the 
digital electron micrographs was carried out by the IMPSYS software package (40) running 
on a VAX 3100 workstation. The mass histograms of the evaluated HsC8 particles were 
fitted by Gaussian curves. 
Correhtion averaging of negatively stained proteasome particles - from digitized electron 
micrographs of negatively stained proteasome particles 64x64-pixel frames of 190 top views 
and 110 side views were selected interactively using the SEMPER 6 image processing 
package (41) installed on a VAX 3100 workstation. For both top views and side views, the 
respective particle images were aligned relative to a single particle reference using cross-
correlation techniques. After alignment, an intermediate reference particle image was 
computed by summing up those particles yielding the highest cross-correlation peak. This 
intermediate reference particle image was then used for a second round of alignment and 
averaging. The final average of the top views included 43 particles having a cross-correlation 
coefficient of >0.85 with the intermediate reference particle. To further enhance the seven­
fold symmetry of the averaged top view, it was also seven-fold symmetrized. Similarly, the 
final average of the side views included 25 particles with a cross-correlation coefficient >0.85. 
To further enhance the two-fold symmetry of the averaged side view, it was also two-fold 
symmetrized. 
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Fig. I . Expression of HsC8 in E. coli. 
A, Coomassie Brilliant Blue-stained 
protein pattern after SDS-PAGE of total 
lysates of bacteria transformed with the 
vector pETI6bHsC8, before (left) and 2h 
after (right) induction with IPTG.The 
asterisk indicates the position of the 
recombinant HsC8 protein. Molecular 
mass of the markers is indicated in kDa. 
ß,Western blot of SDS-PAGE separated 
total bacterial lysate as in A and purified 
human proteasomes, probed with the 
monoclonal antibody MCP72, directed 
against HsC8 protein. 
Results 
Recombinant HsC8 protein forms large complexes 
HsC8 was isolated during the screening of a HeLa cDNA library with the yeast two-hybrid 
system in a search for proteins interacting with the small heat shock protein aB-crystallin 
(W. Boelens et al., in preparation). Since little is known about the structural properties of the 
eukaryotic proteasomal subunits we decided to study the HsC8 protein in more detail. We 
therefore cloned the coding region of the HsC8 cDNA into a pET16b expression vector (32) 
to produce the recombinant protein. Upon induction with IPTG, an E. coli BL21(DE3) 
strain transformed with the pET16bHsC8 construct expresses a protein of about 28 kDa 
(Fig. I A). The amount of recombinant protein constituted up to 50% of total bacterial 
protein. The monoclonal antibody MCP72 directed to HsC8 reacts with this protein (Fig 
15), confirming that the induced protein is HsC8. 
To isolate the recombinant HsC8 protein, we extracted freeze-thawed and lysozyme-treated 
bacteria expressing the HsC8 protein with buffer containing 300 mM NaCl. The amount of 
recombinant protein which remains water-soluble is over 80%. We purified the HsC8 
protein on a Sepharose Q anion exchange column, resulting in >95% pure HsC8 
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4 7 
Fig. 2. The multimeric size of 
recombinant HsC8. A Sepharose Q 
purified HsC8 preparation was separated 
on a Superóse 6 gel permeation column. 
The graph shows the elution profile. 
Fractions were analyzed on a Coomassie 
Brilliant Blue-stained SDS-polyacrylamide 
gel. No protein was detected the minor 
peak at fraction 32. Arrows indicate the 
position of the peak fraction of marker 
proteins; thyroglobulin (670 kDa) and 
ferritin (440 kDa). 
preparations. Peak fractions were pooled and subjected to size exclusion chromatography on 
a Superóse 6 column. The fractions were analyzed by SDS-PAGE. HsC8 is cluted as a large 
complex in a single homogeneous peak (Fig 2) as has also been observed for the a-subunit of 
T. acidophilum (22). By comparing the elution volume of HsC8 protein with that of 
calibration proteins, we estimated the molecular mass of the HsC8-complexes to be 540 ± 30 
kDa. We also analyzed the molecular mass of Sepharose Q purified HsC8-complexes using 
analytical ultracentrifugation. The complex sediments with a sedimentation coefficient uo,w of 
12.5 S, and by sedimentation equilibrium it reveals a molecular mass of 526 kDa which is in 
good agreement with the gel filtration data (see above). 
Electron Microscopy 
The Thermoplasma proteasomal a-subunit appeared to consist of a double ringlike structure 
(22). We wondered whether the HsC8 protein forms a similar complex. Therefore we 
analyzed purified HsC8-complexes by electron microscopy. Electron micrographs of 
negatively stained HsC8-complexcs (Fig. 3Ä) reveal two different images, namely donut- or 
ringlike structures with a diameter of 14.3 ±0.5 nm and double-layered rectangular 
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Fig. 3. Electron micrographs of negatively stained 4 9 
recombinant HsC8-complexes. A, Overview micrograph of 
HsC8-complexes negatively stained with 0.75% uranyl formate 
(pH 4.25). B, Galleries of top (top row) and side (bottom row) 
views of negatively stained HsC8-complexes selected from 
electron micrographs such as shown in A. C, correlation averaged 
top view including 43 HsC8-complexes such as displayed in B, 
unsymmetrized (left) and after enforcing the 7-fold rotational 
symmetry of its rings (middle and right). D, Correlation averaged 
side view including 25 HsC8-complexes such as displayed B, 
unsymmetrized (left) and after enforcing its double-ring structure 
by two-fold symmetrization (middle and right).The left and 
middle panels in С and D are mass density representations of 
protein shown as white with a negative stain dark, whereas in the 
right panel in С and D the mass densities of the symmetrized top 
and side views have been contoured. Scale bars, 100 nm (A), 10 
nm (Q and (D). 
structures, 14.2 ± 0.8 nm χ 12.0 ± 0.8 nm in size. They most likely represent, respectively, 
the top view and side view of a particle consisting of a pair of interacting rings. These images 
are very similar to electron micrographs of the a-subunit of T. acidophilum (22,42). Detailed 
analysis of enlarged top and side views (Fig. 3B), and correlation averaged top and side 
projections (Fig. 3, С and D) revealed that, similar to the α-rings of T. acidophilum (Та), the 
HsC8-rings consist of seven subunits. As can be seen in Fig. 3C, each subunit seems to 
contain two domains, a large outer domain and a smaller inner domain surrounding a low-
mass density center. The center of the HsC8 rings seems to be "plugged", contrary to Ta-a-
rings, which have a small central pore (22). The resolution of structural detail of the 
correlation averaged the side view is too low to decide whether the two stacked rings are out 
of register (Fig. 3D), like in Ta-a-rings, (22) or in a parallel orientation, possibly caused by 
different rotational orientations of the complexes. 
The complex of two heptameric HsC8 rings contains 14 polypeptides of 28.5 kDa and has a 
calculated mass of 400 kDa. This is significantly smaller than the molecular mass determined 
with either gel filtration or ultracentrifugation. Therefore, we also performed STEM mass 
measurement of unstained freeze-dried HsC8 particles (Fig. 4A) as a third mass 
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Fig. 4. Mass determination of purified recombinant HsC8-
complexes by quantitative scanning transmission electron 
microscopy (STEM). A, Low dose (i.e., 300 e /nm ! recording 
dose) STEM image of unstained/freeze-dried purified recombinant 
HsC8-complexes. Scale bar, 50 nm. ß, 361 mass values determined 
from unstained freeze-dried purified HsC8-complexes such as 
displayed in A were histogrammed, and the resulting histogram was 
fitted by a single Gaussian curve. 
determination method. The STEM analysis (Fig. AB) yielded a molecular mass of 530 ± 90 
kDa thus confirming the mass values determined by gel filtration (i.e., 540 ± 30 kDa) and 
analytical ultracentrifugarion (i.e., 526 kDa). The discrepancy between the estimated 
molecular mass and the calculated mass is not clear but might be caused by a relatively large 
space between the two α-rings (Fig 3D). 
Expression of recombinant proteasomal fi-type subunits 
Coexpression of the a- with either the pro-ß-subunit (23) or the mature ß-subunit (22) of 
T. acidophilum in the host К coli resulted in the generation of functional proteasomes. 
To investigate whether such simple eukaryotic proteasome-like particles could be produced 
we performed coexpression of HsC8 with two human proteasomal ß-type subunits. To our 
best knowledge it is not known which ß-type subunit(s) bind to HsC8. Therefore, we chose 
arbitrarily the two ß-type subunits HsBPROS26 and HsDelta. At first, we expressed and 
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characterized the assembly properties of the ß-type subunits alone in their proprotein 
(HsBPROS26 and HsDelta) and mature form (HsBPROS26mat and HsDelta™,) from 
constructs with, respectively, the natural start codon or a start codon placed just upstream of 
the codon for the N-terminal threonine of the processed forms. 
Induction of the ß-type subunits encoded by the different pET constructs resulted in the 
expression of polypeptides in amounts of 10% to 50% of total bacterial protein (Fig. 5A). 
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Fig. 5. Expression of ß-type proteasomal subunits in 
E. coli. A,The Coomassie Brilliant Blue-stained SDS-polyacryl-
amide gel contains total bacterial lysates of bacteria expressing 
the indicated proteasomal subunit, 2 h. after induction with IPTG. 
The control lane contains the lysate of IPTG-induced bacteria 
with an empty рЕТЗс vector.The asterisk indicates the position 
of the recombinant proteasomal proteins. Molecular mass of the 
markers is indicated in kDa. B, Western blots of SDS-PAGE 
separated total bacterial lysates as in A and human proteasomes, 
probed with the monoclonal antibodies directed against the 
relevant proteasomal subunits. 
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52 Only HsDeltamat expression, even in different E. coli BL21(DE3) host strains and using 
several growth conditions, was undetectable by SDS-PAGE and Western blotting (data not 
shown). The expressed proteins were separated by SDS-PAGE and identified on Western 
blots with monoclonal antibodies and compared with the homologous subunit present in 
human placenta proteasomes (Fig. 5B). The bacteria expressing HsBPROS26 contain a 
protein which reacts with the corresponding monoclonal antibody and is, as expected for the 
HsBPROS26 proprotein, larger than the mature proteasomal homologue. HsBPROS26mat 
has about the same mobility on an SDS-polyacrylamide gel as its proteasomal homologue. 
To ascertain that the recombinant HsBPROS26mat indeed contains the wild-type threonine at 
the N-terminus, the N-terminal amino acid sequence has been determined. It appeared that 
20% of HsBPROS26ma, has a free N-terminal threonine, the rest still having the translation 
start methionine at the N-terminus. The protein expressed from the pET-vector encoding the 
HsDelta proprotein, which reacts with the anti-HsDelta monoclonal antibodies, has almost 
the same mobility on an SDS-polyacrylamide gel as the mature proteasomal homologue. 
Only a faint band at the expected position of the unprocessed HsDelta form can be detected 
in some lysates (data not shown). The N-terminal amino acid sequence of the recombinant 
protein is Aloc-Val-Arg-Phe-Asp-Gly, which corresponds with the positions 5-10 in the 
mature protein. This means that the N-terminus is proteolytically cleaved in the bacterium 
or, alternatively, that the second AUG codon, which codes for methionine at position 4 in 
the mature protein, is used as a translation start site. 
The HsBPROS26 proprotein and our mature-like HsDelta, both of which do not have a 
threonine at the N-terminus are thus very likely proteolytically inactive. Furthermore, 
HsBPROS26maI having a threonine at the N-terminus, but lacking other for proteolytic 
activity essential amino acid residues located near the active center (18), may also be inactive. 
To confirm this, we tested the proteolytic activity in crude extracts of bacteria expressing 
ß-type subunits using the fluorogenic test peptide substrates Suc-Leu-Leu-Val-Tyr-MCA, 
BZ-Phe-Val-Arg-MNA and CBZ-Leu-Leu-Glu-ßNA. Such a test was valid to detect the 
proteolytic activity of the archaebacterial ß-subunit (22). As a negative control, we used 
lysates of HsC8-expressing bacteria. We could not detect a significantly elevated activity in 
bacterial extracts containing any of the ß-type subunits, indicating that they indeed are 
proteolytic inactive. 
Molecular mass of the recombinant ß-type subunits 
The molecular masses of HsBPROS26, HsBPROS26mJ, and HsDelta present in the water-
soluble fraction of crude bacterial lysates were determined using size exclusion 
chromatography. About 50% of the HsBPROS26 subunit and only a small fraction (less 
than 10%) of the HsBPROS26mat and mature-like HsDelta proteins are soluble in buffer 
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Fig. 6. The size of the soluble recombinant ß-type 
proteasomal subunits present in bacterial lysates. The 
water-soluble fraction of bacteria expressing HsC8 or a ß-type 
proteasomal subunit was separated on a Superóse 12 gel 
permeation column. Fractions were analyzed on Western blots 
and probed with the relevant monoclonal antibodies.Arrows 
indicate the position of the peak fraction of marker proteins; 
thyroglobulin (670 kDa) and chymotrypsinogen A (25 kDa). 
containing 300 mM NaCl. The pro-ß-subunit and mature form of T. acidophilum behave 
also differently (22). Fig. 6 displays Western blots of fractions obtained with the molecular 
mass determination on a size-calibrated Superóse 12 column. The soluble ß-type subunits 
have much smaller molecular masses than the HsC8 subunit. Both the ß-type HsBPROS26 
and HsBPROS26ma, emerged at the monomer position of about 30 kDa. In contrast the 
HsDelta subunit is eluted at the tetramer position (Fig. 6). Thus, both ß-type subunits do 
not form ring structures upon recombinant expression in the absence of other proteasomal 
subunits. 
Coexpression ofHsC8 with ß-type subunits 
In order to test whether the human ß-type subunits, like in T. acidophilum, can assemble into 
proteasome-like particles with the HsC8-complex, we coexpressed HsC8 with HsBPROS26, 
HsBPROS26mat or the mature-like HsDelta. The presence of both HsC8 and a ß-subunit in 
IPTG-induced bacteria was confirmed on Western blots (data not shown). It appeared that 
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HsDeltamat also could not detectably be expressed in combination with HsC8. Coexpression 
of the ß-type subunits with HsC8 does not result in a change in solubility of the 
recombinant subunits (data not shown). The water-soluble fraction of bacteria coexpressing 
HsC8 with one of the ß-type subunits was separated on a Superóse 6 column and the 
fractions were analyzed by Western blotting (Fig. 7). Elution profiles of HsC8 obtained with 
single expression of HsC8 and coexpression with the ß-type subunits were similar (data not 
shown). Upon coexpression with HsC8 a significant amount of HsBPROS26 is present in 
the HsC8-containing higher molecular mass fractions. There is, however, still HsBPROS26 
present in the monomer region, although HsC8 is present in at least five-fold excess (data 
not shown). The molecular mass of the HsC8-HsBPROS26 complex is not increased up to 
the size of proteasomes (which are eluted in fraction 4, data not shown), indicating that 
HsBPROS26 cannot form a ring-structure on the HsC8-complex. The ß-type subunit is 
Fig. 7. The multimene size of the proteasomal ß-type subunits 
coexpressed with HsC8 in bacterial lysates. The water-soluble 
fraction of bacteria coexpressing HsC8 with a ß-type proteasomal subunit 
was separated on a Superóse 6 gel permeation column. Fractions were 
analyzed on Western blots probed with the relevant monoclonal 
antibodies. Similar elution profiles of HsC8 were obtained from Superóse 
6 runs of the three preparations used, therefore only the Western blot of 
the HsC8-HsBPROS26 separation probed with anti HsC8 antibodies is 
shown. Arrows indicate the positions of marker proteins as in Fig. 6. 
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also not processed into the mature form and no proteasomal activity is present in the HsC8- 55 
HsBPROS26 fraction. Furthermore, we did not observe a change in the elution profile of 
HsBPROS26mat and mature-like HsDelta on a Superóse 6 column when coexpressed with 
HsC8, compared to single expression. Thus coexpression of the ring-forming α-type subunit 
HsC8 with two different ß-type subunits does not result in the formation of proteasome-like 
complexes, suggesting that for their formation other a- and ß-type subunits are needed. 
Discussion 
In this report we present the first detailed investigation of the assembly properties of isolated 
eukaryotic proteasome subunits. We show that the recombinant eukaryotic proteasomal 
α-type subunit HsC8 forms ringlike structures. Accordingly, the HsC8-subunits assemble 
into double-ring type structures with two rings, consisting of seven subunits each, stacking 
on top of each other. Rings containing seven subunits were also found in protcasomes of 
eukaryotes (43,44) and T. acidophilum (7). Recombinant Ta-a-subunits also form complexes 
consisting of two heptameric rings. Correlation averaged top views of both complexes appear 
very similar (compare Fig. 3Cwith Fig. 4 in Zwickl et al. (22)). A remarkable difference 
between the human and archaebacterial complexes is that the Ta-a-complex reveals a small, 
stain-filled hole in the center which is apparently far less pronounced or absent in HsC8-
rings. Unfortunately, the resolution in the side views of HsC8 double rings is not sufficient 
to distinguish if the two rings are staggered, like the Τα-α-rings, or in register relative to each 
other. 
The observation that the eukaryotic HsC8 forms rings in the absence of other a-type 
proteasomal subunits was surprising, since in eukaryotic protcasomes the α-rings may consist 
of seven different subunits (8,36). Indications for this are that in purified proteasomes from 
human placenta (36,37) and yeast (45) all seven α-type subunits are found, and that in yeast 
all α-type subunits except Y13 are essential for life (see (8) and references therein). 
Furthermore, immuno-EM localization studies of the α-type subunits HsPROS30/HC2 and 
XAPC7 (10) and the ß-type subunit HsBPROS26/HN3 (11) in human placenta 
proteasomes indicated that these subunits were present in two copies per proteasomal 
particle. The property of HsC8 to form rings may, however, indicate that this subunit can 
actually occupy several positions in α-rings of proteasome(-like) particles, which would result 
in proteasome subpopulations differing in the content of α-type subunits. Such 
compositional variation could explain why the monoclonal antibody p31k (46), which is 
directed to HsC8 ((47), W. Gerards, unpublished observations) stained mainly areas in rat 
liver cells which are close to the bile canaliculi, whereas a much more general staining was 
obtained with a polyclonal antiserum directed to proteasomes (48,49). Also in C2.7 
myoblasts (50), LCLC103 lung carcinoma cells and the adherent fraction of NCI-H524 lung 
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56 carcinoma cells (В. Machiels, personal communications), and cells in some stages of early 
embryonic development of the newt Pleurodeles waltl (51), the p31k antibody gave different 
staining patterns as compared to the monoclonal antibodies directed to other a-type 
subunits. On the basis of the present results it is not clear whether putative proteasomal 
complexes with a high HsC8 content are assembly intermediates or functional proteasome 
complexes. 
Proper folding, assembly and processing of the ß-subunits of T. acidophilum is chaperoned by 
the α-rings (22,24). The formation of an a-subunit ring is therefore the first event in 
assembly. Coexpression of the Ta-α and Ta-ß-subunits in E. coli produces functional 
protcasomes. Since HsC8 forms similar rings, these complexes may be important for 
proteasome assembly in eukaryotes. However, coexpression of the ring-forming HsC8 and 
the ß-type subunits HsBPROS26, HsBPROS26mat or HsDelta did not yield proteasome-like 
complexes, although a fraction of HsBPROS26 does bind to HsC8. Moreover, coexpression 
of ß-type subunits with HsC8 did not change their solubility either (data not shown) 
indicating that HsC8 does not chapetone the proper folding of these proteins. The three 
human ß-type subunits tested thus apparently cannot bind properly to HsC8 rings. This 
means that the HsC8 tings and Ta-a-rings behave differently since the Ta-a-rings can 
assemble into proteasome-like particles with both processed and unprocessed Ta-ß-subunits 
(24). A possible explanation is that eukaryotic ß-subunits do interact with two different 
α-type subunits in the proteasome, which define a binding pocket for a certain ß-type 
subunit. This is possible since the a- and ß-rings are about 25° out of register, which is 
approximately half a subunit (6,7,52). Thus, the HsC8 ting may be an important complex 
for proteasome assembly, but before ß-type subunits can bind properly to the α-ring, the 
latter needs to consist of different α-type subunits. In this respect it is of interest whether 
the ability of HsC8 to form rings by itself is a general feature of human α-type subunits. 
If so the variability in the subunit composition of proteasomes may be more extended than is 
believed presently. Alternatively, if only HsC8 can form rings, these rings may be a start 
point for proteasome assembly. As can also be concluded from the recent work on processing 
and assembly of ß-type subunits in yeast (13), our data confirms that proteasome assembly 
in eukaryotes is much more complex than in archaebacteria. 
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The human proteasomal 
subunit HsC8 induces 
ring formation of other 
α-type subunits 
CHAPTER 4 
Summary 
The eukaryotic 20S proteasome is a barrel-shaped protease complex, made up of four seven-
membered rings. The outer and inner rings contain seven different a- and ß-type subunits, 
respectively, each subunit located at a defined position. Recently, we have reported that the 
recombinant human α-type subunit C8 (HsC8), assembles into a heptameric ringlike 
structure by itself. In the present study we show that the two naturally neighboring a-type 
subunits of HsC8, HsPROS30 and HsPROS27, do not form ringlike complexes by 
themselves, but only dimers. This indicates that the propensity to form homo-oligomeric 
rings is not a general feature among human α-type subunits. However, coexpression of HsC8 
and either of these neighbor α-type subunits results in the formation of hetero-oligomeric 
ring complexes, resembling the HsC8 ringlike structure. The ratio between the two types of 
subunits in the mixed complexes is surprisingly heterogeneous, varying from very high to 
very low HsC8 content. The three tested α-type subunits thus apparently lack binding sites 
that selectively interact with a specific neighboring subunit. This suggests that the correct 
positioning of the different α-type subunits in the eukaryotic 20S proteasome is not dictated 
by the α-type subunits themselves, but rather by the interaction with specific ß-type 
subunits. 
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62 Introduction 
In eukaryotes, che 20S proteasome is the major non-lysosomal protease, which can form 
together with the 19S regulatory complex, the 26S proteasome. The 26S complex is 
responsible for the ubiquitin-dependant turnover of cytosolic and nuclear proteins (Coux et 
al, 1996; Peters, 1994; Hochstrasser, 1995). This proteasome-ubiquitin pathway has an 
essential function in the cell, being involved in processes such as cell cycle progression (Hilt 
& Wolf, 1996), antigen presentation (Coux et ai, 1996) and apoptosis (Sadoul et ai, 1996; 
Grimm et al, 1996). The 20S proteasome is a mul tica talytic enzyme with at least five 
different protease activities (Rivett, 1993). The complex comprises 28 subunits, arranged in 
a stack of four seven-membered rings, which form a barrel-shaped structure of about 
700,000 M
r
 (Koster et al, 1995). A relatively simple 20S proteasome was isolated from the 
archaebacterium Thermoplasma acidophilum, consisting of only two different subunits, 
named α and β (Dahlmann et al, 1989). In contrast, several different but related eukaryotic 
proteasomal subunits have been characterized, which can be distinguished into two groups, 
a- and ß-type, based on their similarity to either the a- or ß-subunit of T. acidophilum 
(Scherrer &C Bey, 1994; Hilt & Wolf, 1996). The a-subunits reside in the two outer rings, 
and the ß-subunits form the two inner rings of the 20S proteasome (Kopp et al., 1997; 
Groll étal., 1997; Schauer et ai, 1993; Kopp et al, 1995; Kopp et ai, 1993; Löwe et al, 
1995; Pühler et al, 1992). Importantly, the different α- and ß-subunits in the eukaryotic 
proteasome are not randomly distributed within the respective rings, but occupy defined 
positions, resulting in an αι.7βι.7βι.7αι.7 complex (Chen & Hochstrasser, 1996; Schauer et al, 
1993; Kopp étal, 1995; Kopp et al, 1993; Kopp et al, 1997; Groll et al, 1997). Thus, the 
20S proteasome can be regarded as a complex dimer with a symmetrical arrangement of 
2x14 different subunits along the cylinder main axis (Kopp et al, 1993). 
The assembly of the eukaryotic proteasome particle is as yet poorly understood. Assembly 
intermediates of 13-16S, containing at least six different α-type subunits and several 
unprocessed ß-subunits, have been documented (Schmidtke et al, 1997; Yang étal, 1995; 
Patel et al, 1994; Frentzel et al, 1994). Processing of some рго-ß-subunits takes place in the 
16S complex, during the final formation of the active 20S complex (Schmidtke et al, 1997; 
Schmidtke et al, 1996; Chen & Hochstrasser, 1996; Frentzel et ai, 1994). The assembly of 
13-16S complexes into the 20S complex is a relatively slow process, and translation-
dependent (Yang et al, 1995; Frentzel et al, 1994). In T. acidophilum the formation of 
α-rings is most likely the first step in proteasomal assembly (Zwickl et al, 1994). A box 
of approximately 25 amino acids at the N-terminus, highly conserved in all α-type subunits, 
is essential for this ring formation. Subsequently, the α-rings chaperone the folding, assembly 
and autocatalytic processing of the ß-type subunits into the mature T. acidophilum 
proteasome (Seemüller et al, 1996; Zwickl étal, 1994; Zwickl étal, 1992). 
A S S E M B L Y O F H U M A N P R O T E A S O M A L A L P H A I U I I I N I T ! 
Like the α-subunit of Τ aadophilum, the recombinant human α-type subunit C8 (HsC8) 63 
forms a double ring structure by itself (Gerards et al, 1997) The role of HsC8 in the 
assembly process is, however, different from that of the Τ aadophilum cc-subunit, since 
HsC8 does not form 20S complexes with recombinant human ß-subunits (Gerards et al, 
1997) In this study we investigated whether HsC8 has a role in the assembly of different 
α-type subunits into the ring complex We show that the naturally neighboring subunits of 
HsC8 in the human 20S proteasome (see (Kopp et al, 1997, Groll étal, 1997), HsPROS30 
((Silva-Pereira étal, 1992), also called HsC2) and HsPROS27 ((Bey et al, 1993), also called 
Hslota), do not occur as rings but form dimers in vitro However, upon coexpression with 
HsC8 these α-type subunits assemble into hetero-oligomeric ring structures These ringlike 
complexes have a very variable subunit composition, which indicates that the three analyzed 
α-type subunits do not have a preference for a specific neighboring subunit This result 
suggests that not the α-type but rather the ß-type subunits play an important role in the 
correct positioning of the α-type subunits in the 20S proteasome 
Results and Discussion 
Not all recombinant human α-type subunits form ring complexes 
To test whether the ability of HsC8 to form ring structures is a general feature of human 
α-type subunits, we analyzed the assembly properties of HsPROS30 and HsPROS27, which 
both are naturally neighboring subunits of HsC8 in the human 20S proteasome (Kopp et al, 
1997, Groll et al, 1997) The subunits were produced from pE I-expression constructs 
(Table I) in Ь coli BL21(DE3) (Studier étal, 1990) SDS-PAGE analysis of total lysates of 
Table I. Characteristics of the α-type proteasomal subunits studied. Molecular masses 
and pi were calculated from the predicted amino acid sequence encoded by the expression 
constructs, using the Pepstats program of the CAOS/CAMM computer facility of the University 
of Ni|megen 
subunit expression construct molecular mass pi 
kDa 
HsPROS30 pET3cHs30 30 6 6 
HsPROS27 pET3cHs27 27 5 6 7 
HsC8 pETI6bHsC8,pET24dHsC8 28 5 5 1 
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bacteria expressing HsPROS30, HsPROS27 or HsC8 (see also (Gerards et αι., 1997)) reveals 
that upon induction the bacteria produce a large amount of the recombinant proteins (Fig. 
la). These proteins have the correct monomeric size and react with the proper antibodies 
(Fig. 1 b), thus confirming that they are the expected proteasomal subunits. The water-soluble 
fraction of bacteria expressing the proteasomal subunits was isolated lor molecular mass 
estimation. More than 80% of each recombinant subunit was in the water-soluble ftaction. 
On a Superóse 12 size exclusion column, both HsPROS30 and HsPROS27 are eluted at the 
dimer position (Fig. le). A similar result was obtained on a Superdex 75 column (data not 
shown). Thus, in contrast with HsC8, which forms a double ring complex (Gerards et al., 
1997) of 550 kDa (Fig. lc), both HsPROS30 and HsPROS27 clearly do not form such 
complexes by themselves. This is most likely not due to aberrant folding of the latter two 
proteins, as indicated by their good solubility and lack of degradation products in the 
bacterial lysates. This means that the property of HsC8 to form rings by itself is not a general 
feature of human α-type subunits. 
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Fig. I. Expression in E. cod' and size determination of 65 
human α-type proteasomal subunits. o.Tocal bacterial 
lysates of bacteria expressing the indicated proteasomal subunit, 
2 h after induction with IPTG.The lysates were separated by 
SDS-PAGE and stained with Coomassie Brilliant Blue.The 
control lane contains the lysate of IPTG-induced bacteria with an 
empty рЕТЗс vector.The asterisks indicate the positions of the 
recombinant proteasomal proteins. Molecular masses of the 
markers (M) are indicated in kDa. b, Western blot of total 
bacterial lysates, as in a, and human proteasomes after SDS-
PAGE and probing with the monoclonal antibodies, as indicated 
above each two lanes, directed against the relevant proteasomal 
subunits. c, Complex size of the recombinant α-type subunits. 
The water-soluble proteins of bacteria expressing HsC8, 
HsPROS30 or HsPROS27 were fractionated on a Superóse 12 
size exclusion column.The fractions were analyzed on Western 
blots which were probed with the relevant monoclonal anti-
proteasomal subunit antibodies. Arrows indicate the positions of 
the peak fraction of marker proteins: thyroglobulin (670 kDa), 
BSA (67 kDa) and chymotrypsinogen A (25 kDa). 
HsPROS30 and HsPROS27 are incorporated in large complexes upon coexpression with HsC8 
Since HsPROS30 and HsPROS27, in contrast to HsC8, do not form ring structures by 
themselves, we envisaged that the HsC8 complex might play an important role in the 
assembly of the eukaryotic proteasomal α-ring. HsC8, of which presumably only one subunit 
is present in each α-ring of the mature proteasome, may form a scaffold to which the other 
α-гуре subunits are joined. Therefore, we assessed whether HsPROS30 and HsPROS27, 
which both are naturally neighboring subunits of HsC8 in the proteasome, occur in higher 
molecular mass complexes upon coexpression with HsC8 in Exoli. The water-soluble 
proteins of bacteria coexpressing HsC8 and HsPROS30, or HsC8 and HsPROS27, were 
first fractionated on a non-denaturing Sepharose Q (SQ) anion-exchange column (Fig. 2). 
HsPROS30 and HsC8 are eluted in a broad peak at slightly different salt concentrations 
(Fig. 2a, b). The first peak fractions consist mainly of HsPROS30 (fractions 3-5), whereas 
the last peak fractions contain almost exclusively HsC8 (fractions 9-13). The 
HsC8:HsPROS30 ratio changes gradually between the two extremes. Also HsPROS27, 
C H A P T E R 
coexpressed with HsC8, is eluted from a Sepharose Q column as a broad peak in which the 
ratio between the two proteins varies gradually (Fig. 2c). 
To examine the effect of coexpression with HsC8 on the complex size of HsPROS30, we 
subjected the Sepharose Q fractions 4, 7 and 9 to size exclusion chromatography. 
Interestingly, in all three fractions HsPROS30 is eluted together with HsC8 in a single peak 
as large complexes with molecular masses of 575 up to 605 kDa (Fig. 3). The apparent 
molecular mass of the complexes is slightly larger than that of the pure HsC8 complex 
(about 560 kDa) which corresponds with the difference in molecular mass between the 
HsPROS30 subunit and the HsC8 subunit. A similar result was obtained with HsPROS27 
3 4 5 6 7 8 9 10 I I 12 13 14 
I ^щцу' HsPROS30 HsC8 
_HsC8 
" HsPROS27 
Fig. 2. Fractionation of 
bacterial extracts coexpres-
sing HsC8 and HsPROS30 or 
HsC8 and HsPROS27. 
a, Sepharose Q anion-exchange 
chromatography of the bacterial 
extract containing HsC8 and 
HsPROS30. Graphs represent the 
applied salt gradient (dotted line) 
and the obtained elution profile 
(solid line).A similar pattern was 
obtained when a bacterial extract 
containing HsC8 and HsPROS27 
was applied (not shown). 
b, Coomassie Brilliant Blue-
stained protein pattern after 
SDS-PAGE of Sepharose Q 
fractions from HsC8+HsPROS30. 
c, Western blot after SDS-PAGE 
of Sepharose Q fractions contai­
ning HsC8+HsPROS27, probed 
with the monoclonal antibodies 
MCP72 and p27k. Lane i contains 
the input, and the numbered 
lanes correspond with the 
fractions in a. 
B L V O F H U M A N P R O T E A S O M A L A L P H A S U 
Fig. 3. HsPROS30 assembles into large complexes upon 
coexpression with HsC8. Three of the Sepharose Q fractions shown in 
Fig 2b, containing mainly HsPROS30 (fraction 4) or HsC8 (fraction 9) or 
an equal amount of both subunits (fraction 7), were applied to a Superóse 
6 size exclusion column.The upper panel shows the elution profiles. 
Arrows indicate the peak positions of the marker proteins, thyroglobulin 
(670 kDa) and ferritin (440 kDa), used to estimate the indicated molecular 
masses. Peak-fractions were analyzed on SDS-polyacrylamide gels stained 
with Coomassie Brilliant Blue (lower panel); i is the input. 
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Fig. 4. Electron micrographs of HsC8-HsPROS30 
complexes. Panels show the negatively stained complexes in 
the peak fractions of the three Superóse 6 separations of HsC8 
and HsPROS30 depicted in Fig. 3 (top panel), representing 
fractions 4, 7 and 9 of the Sepharose Q column. Arrows 
indicate side views of double ring structures. Scale bar, 100 nm. 
coexprcssed with HsC8 (data not shown). Thus, contrary to single expression of HsPROS30 
or HsPROS27, resulting in apparent dimers, both these α-type subunits are present in a 
much larger complex upon coexpression with HsC8. 
HsC8 induces ring formation of HsPROS30 
The size of the HsC8-HsPROS30 and HsC8-HsPROS27 complexes suggests that they may 
exist as a pair of heptameric rings similar to the HsC8 complex. EM-analysis of the three 
different HsC8-HsPROS30 containing peaks in Fig. 3 (top) confirms that all observed 
complexes consist of ringlike structures (Fig. 4). They have a diameter of 14 ± 1 nm and are 
indistinguishable from pure HsC8 rings (see Gerards et αι., 1997). Images of two parallel-
oriented rods are present in all three electron micrographs (arrows), indicating that the 
complexes consist of two stacked heptameric rings. Based on the similarity of HsC8 and 
A S S E M B L Y O F H U M A N P R O T E A S O M A L A L P H A S U B U N I T S 
anti-HsC8 pre-imm. 
HsPROS30 4 7 9 7 
Fig. 5. HsC8 and HsPROS30 form mixed complexes. The Sepharose 
Q fractions 4, 7 and 9 (see Fig. 2b), and as a control the water-soluble 
fraction of single expressed HsPROS30, were immunoprecipitated with 
an anti-HC8 polyclonal antiserum.The input and precipitates (ip) were 
analyzed by non-reducing SDS-PAGE and subsequent Coomassie Brilliant 
Blue staining of the gels. As a control a pre-immune serum was used. 
HsC8-HsPROS30 complexes with respect to molecular mass, diameter and EM-structure, 
the mixed ring complexes probably also contain 2x7 subunits. 
HsC8-HsPROS30 rings are hetero-oligomers containing at least one HsC8 subunit 
The above experiments do not reveal whether the ring particles exist as hetero-oligomeric 
complexes, composed of a mixture of the two different α-type subunits or, alternatively, as 
two different homo-oligomeric complexes, each containing a single type of a-subunit. To 
distinguish between these two possibilities, immunoprecipitations were performed on the 
HsC8-HsPROS30 containing Sepharose Q fractions 4, 7 and 9 with a polyclonal antiserum 
raised against HsC8 (Fig. 5). Using this serum, HsPROS30 is not precipitated from bacterial 
lysates expressing HsPROS30 alone, but it does coprecipitate via HsC8 from the fractions 4, 
7 and 9. The HsC8:HsPROS30 ratio of input and precipitate is very similar, indicating that 
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70 most if not all of the rings contain both HsC8 and HsPROS30. The formation of stable 
mixed complexes with different HsC8 and HsPROS30 ratios was also confirmed by 
rechromatography of the three Sepharose Q fractions on the same column. Proteasomal 
subunits of each fraction are eluted in a single peak, at a salt concentration corresponding 
with the initial run on the column (data not shown). Also HsC8-HsPROS27 complexes 
containing completely different ratios of the two proteins could be precipitated via HsC8 
(data not shown). Thus, HsC8 and at least either one of its naturally neighboring subunits 
can form hetero-oligomeric complexes with a similar molecular mass as the HsC8 complex, 
in which the ratio between the two proteins is extremely variable. 
The existence of complexes consisting mainly of HsPROS30 indicates that two HsPROS30 
subunits can be neighbors in a ring. Therefore, it is peculiar that single expressed HsPROS30 
does not form ring structures. Incubation of separately expressed HsC8 rings and 
HsPROS30 results in the binding of only a small amount of HsPROS30 to the HsC8 rings 
(data not shown). The exchange of subunits between ring complexes is an very inefficient 
process, which very likely is caused by the high stability of the complex (data not shown). 
This means that HsPROS30 probably will not be exchanged with the α-type subunits 
already located in the ring and that preformed dimeric HsPROS30 does not have the proper 
conformation for ring formation upon HsC8 addition. Coexpression with HsC8 thus seems 
to be essential for efficient ring formation of HsPROS30. A possible role for HsC8 might be 
that a single monomeric HsC8 subunit, or a HsC8 subunit at either end of an incomplete 
ring, can bind HsPROS30 and keep it in a conformation that allows an other a-type 
subunit to join. This would imply that each complex contain at least one HsC8 subunit. 
To investigate this, Sepharose Q fraction 4 was depleted of HsC8 by three sequential 
immunoprecipitation steps with anti-HsC8. The final supernatant still contains a small 
amount of HsPROS30 (less than 5% of the input) but almost no HsC8 (Fig 6a). The 
remaining HsPROS30 is eluted from a Superóse 6 column at the dimcr position (Fig. 6b), 
like the single expressed HsPROS30. The apparent absence of large homo-oligomeric 
HsPROS30 complexes indicates that at least one HsC8 subunit is present in all HsPROS30 
ring complexes, suggesting that HsC8 is essential for the assembly of the hetero-oligomeric 
ring complexes. 
The composition of the α-rings may be regulated by the ß-type subunits 
Our data show that the composition of complexes consisting of two α-type subunits is 
extremely variable. The ratio of HsPROS30 and HsC8, and also of HsPROS27 and HsC8, 
in the ring complex may vary between 1:7 and 7:1, and all combinations in between. Thus, 
in these ring complexes, both HsPROS30 and HsPROS27 can have itself or HsC8 as 
neighbor subunit on both sides. This flexibility seems in contrast with the fact that in the 
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Fig. 6. HsC8-HsPROS30 rings contain at least one 
HsC8 subunit, α, Sepharose Q fraction 4 was depleted of 
HsC8 via three consecutive immunoprecipitation steps with 
anti-HsC8 coupled to Sepharose beads.The three immuno-
precipitates and the final supernatant were analyzed as in 
Fig. 5. b.The molecular mass of complexes containing only 
HsPROS30 (sup 3) was estimated on a Superóse 6 column. 
Fractions were subjected to SDS-PAGE, blotted and probed 
with anti-HsPROS30 monoclonals. 
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72 eukaryotic 20S proteasome each α-type subunit occupies a given position with two defined 
neighbor subunits (Schauet et ai, 1993; Kopp et al., 1995; Kopp et ai, 1993). Our results 
clearly show that the tested α-type subunits do not contain a binding site for a specific 
neighboring α-type subunit. To reconcile these distinct observations we conjecture that the 
ß-type subunits have an important role in the correct positioning of subunits in the matute 
α-ring. This would be in agreement with the finding that in the crystal structure of the yeast 
20S proteasome especially α-β and β-β contacts are very specific (Groll et ai, 1997). If ß-type 
subunits determine the correct positioning of the α-type subunits, it probably is too simple 
to try and understand the assembly of the eukaryotic proteasome by extrapolating the model 
for the Τ acidophilum proteasome, which starts with the formation of a complete α-ring, 
followed by the binding of the ß-type subunit precursors. It is more likely that the assembly 
of the a- and the ß-type subunits in the eukaryotic proteasome occurs in a coordinate 
fashion; a given α-type subunit binds to a defined ß-type subunit which in turn determines 
the next a-type subunit to bind, and so on. This is in accordance with the finding that the 
13S-16S proteasomal intermediates contain both a- and ß-type subunits (Yang et al., 1995; 
Patel et al, 1994; Frentzel et al, 1994). In the eukaryotic assembly process, the HsC8 
subunit might have an important function in initiating a very early step of the ring 
formation. 
Materials and Methods 
Cloning strategies. 
Primers were purchased from Eurogentec. The TViroI and Nde\ sites in the primer sequences 
are underlined. The cloning of HsC8 cDNA has been described previously (Gerards et al, 
1997). 
The HsPROS30 (Silva-Pereira et al, 1992) and HsPROS27 (Bey et al, 1993) cDNAs were 
a gift of Dr. K. Scherrer. In the HsPROS30 cDNA an Nde\ restriction site overlapping the 
natural start codon was generated by site-directed mutagenesis using the oligonucleo 
tide-directed in vitro mutagenesis system (Amersham) and the mutagenic primer 
5'-TCTCCTGGAAATÇATArGCAGCTCAGC-3'. The Ndel-Hincll fragment of the 
mutated cDNA and the Hindi-BarriHl fragment (which contains a natural Ndel site) of 
the original clone were together ligated into the Ndel-BamHl sites of the рЕТЗс expression 
vector. The sequence adjacent to the natural start codon of the HsPROS27 cDNA was also 
converted to form an Ndel site by site-directed mutagenesis with the mutagenic primer: 
5'-ACACACTGAACCArArGGTGACGGG-3'. The NdA-BamHl fragment was 
cloned into the Ndel-BamHl sites of рЕТЗс. Mutated cDNAs were checked for 
correctness by sequencing with the Sequenase vetsion 2.0 sequencing kit (United States 
Biochemicals). 
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Expression of recombinant proteins and fractionation of bacterial iysates. 73 
The proteasomal subunits were expressed separately or coexpressed with HsC8 in the E. coli 
strain BL21(DE3) (Studier et ai, 1990) as described previously (Gerards et ai, 1997). 
Briefly, pET-vector containing bacteria were grown in the presence of appropriate antibiotics. 
At an Λ550 the expression of the proteasomal subunits was induced by adding isopropyl-1-
thio-ß-D-galactopyranoside (IPTG, Research Organics) to a final concentration of 1 mM. 
Bacteria were harvested 3 h after induction by centrifugation at 5000 X g for 15 min. 
Bacterial pellets were resuspendcd in 1/25 volume of the culture volume inTEN300 (50 
mM Tris/HCl pH 8, 0,5 mM EDTA, 300 mM NaCl) and frozen at -80°C. To isolate the 
water-soluble fraction the bacteria were thawed at 37°C, subsequently lysed with chicken egg 
white lysozyme (Sigma) and centrifuged for 30 min. at 90,000 X gat 4°C. The supernatant 
(water-soluble fraction) was used for isolation and analysis of the proteasomal subunits. 
Purification and molecular mass determination of proteasomal subunits. 
Recombinant HsC8 was purified from the bacterial water-soluble fraction as described 
previously (Gerards et al., 1997). The HsC8-HsPROS30 complexes were separated on a 
Sepharose Q Fast Flow column (Pharmacia) in conjunction with a Biorad Econo system. 
After loading the water-soluble fraction of bacteria coexpressing HsC8 and HsPROS30 the 
column was washed with TEN300, and proteins were eluted with a linear gradient from 
300 to 600 mM NaCl. Three fractions with a different HsC8-HsPROS30 ratio were 
concentrated in an Amicon ultrafiltration cell with a 10-kDa-cutofTf filter (Filtron). For final 
purification and molecular mass determination the concentrated fractions were applied on a 
Superóse 6 HR 10/30 prepacked size exclusion column (Pharmacia-LKB) on an LKB 
Bromma HPLC system. HsC8-HsPROS30 complexes were eluted with TEN300 at a flow 
rate of 0.5 ml/min. Absorbance was monitored at 225 nm. The column was calibrated with 
high molecular mass standards (Pharmacia-LKB) as indicated in the legends. 
Analytical gel filtration. 
The molecular weight of the proteasomal subunits and subunit complexes present in 
bacterial water-soluble fraction was estimated by FPLC gel filtration in TEN300 buffer. 
Three different size exclusion columns were used; Superóse 6 HR 10/30, Superóse 12 HR 
10/30 and Superdex 75 Hiload 16/60 (Pharmacia-LKB) with separating range of 50-5000 
kDa, 5-300 kDa and 5-70 kDa, respectively. Column fractions were analyzed by SDS-PAGE. 
Gels were stained with Coomassie brilliant blue or blotted on nitrocellulose and probed with 
antibodies directed against a specific proteasomal subunit. Monoclonal antibodies used are 
MCP72, directed against HsC8 (Kristensen et al, 1994; Hendil et al., 1995), kindly 
provided by Dr. K. Hendil; p27k (IB5) against HsPROS27 (Grossi de Sa étal, 1988) and 
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74 рЗО-ЗЗк (62A32) against HsPROS30 (Silva-Pereira et ai, 1992), both kindly provided by 
Dr. K. Scherrer or purchased from Organon Teknika. Gel filtration columns were calibrated 
with molecular markers (Pharmacia-LKB) as indicated in the legends. 
Immunoprecìpitatìon. 
Protein Α-conjugated Sepharose beads (Kem-En-Tec) were washed three times in KHN-
buffer (100 mM KCl, 20 mM Hepes, pH 7.5, 0.05% NP40) and 20 μΐ beads were 
incubated with 30 μΐ polyclonal anti-HC8 serum in 1 ml KHN-buffer for 2 h. After three 
washes with KHN-buffer the beads were incubated with the Sepharose Q fractions 4, 7 and 
9 for 2 h. The beads were washed three times with KHN-buffer and subsequently treated 
with SDS-sample buffer without ß-mercaptoethanol. Precipitates and supernatants were 
analyzed using SDS-PAGE and Coomassie Brilliant Blue staining of the gels. 
Electron microscopy. 
The samples taken from the Superóse 6 peak fractions containing the different HsC8-
HsPROS30 complexes were diluted three times with double-distilled water (final protein 
concentration ±0.1 mg/ml) and a drop was applied on a glow-discharged, carbon-coated 
collodium film on a copper grid. After 2 min, excess liquid was removed using filter paper, 
and the sample was fixed in 1% paraformaldehyde for 2 min. Subsequently, the grid was 
washed with 5 drops of 0.1% ammonium acetate, stained with 1% uranyl acetate, and air-
dried after removal of excess liquid with filter paper at the edge of the grid. The specimens 
were examined in a Jeol 1210 transmission electron microscope at 100 kV. Electron micro-
graphs were recorded on AGFA Scientia EM 23D56 film at a magnification of 50.000 x. 
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Detailed analysis 
of cell cycle kinetics 
upon proteasome 
inhibition 
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Summary 
We have studied specific effects of proteasome inhibition on cell cycle progression. To this 
end the protease inhibitors MG115, calpain inhibitor I and calpain inhibitor II, which 
display differential inhibitory effects on proteasomes, were used. Cell kinetic studies using 
bromodeoxyuridine pulse labeling revealed a complete block of Gl/S and metaphase 
transitions and a delayed progression through S phase in cell cultures treated with 54 μΜ 
of MGI 15. Calpain inhibitor I in similar concentrations displayed a 5 fold lower effect on 
cell cycle kinetics. Calpain inhibitor II and MG2M, a structural analogue of MG 115, had 
no effect on the cell cycle. The inhibitory effect of MG115 treatment was reversible, since 
the cell cycle was immediately resumed when the MG115 containing culture medium was 
replaced by fresh culture medium. Since ubiquitinated proteins accumulated after MG115 
treatment, it was confirmed that ubiquitin dependent protein degradation, thus proteasomal 
activity, was blocked. By comparison of biochemical and in vitro proteasome inhibition 
experiments it was hypothesized that chymotrypsin-like activity of proteasomes may play 
an important role in cell cycle kinetics. 
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80 Introduction 
The cell cycle is a highly regulated event, in which successive protein synthesis, activation 
and subsequent deactivation occurs. Cyclin dependent kinases (CDK's), a family of highly 
conserved proteins playing an important role in cell cycle regulation, are expressed 
throughout the cell cycle. These CDK's form complexes with specific members of the cyclin 
family, a class of conserved proteins that show cell cycle dependent expression. Distinct 
mechanisms are involved in activation and deactivation of the cyclin-CDK complexes: 
1) site specific phosphorylation or dephosphorylation of the CDK subunit, 2) proteolytic 
degradation of cyclins and 3) binding or release of inhibitory proteins. 
Recently, several lines of evidence for the involvement of ubiquitin dependent proteolysis in 
the second and third mechanism have been presented. For instance, the expression of cyclin 
В starts in very late S phase and the protein is further accumulated during G2 and early 
M phase. During these phases cyclin В is complexed with the CDK cdc2. The activity of 
the cyclin B-cdc2 complex is regulated by phosphorylation and dephosphorylation of specific 
amino acids of cdc2 (29). However, the activated complex has to be destroyed for progres­
sion through anaphase (7). This may be achieved by ubiquitination of the cyclin В subunit 
and subsequent degradation by proteasomes (7). 
Furthermore, exit from G l and entrance of S phase are also controlled by a specific class 
of cyclin-CDK complexes, involving the Gl cyclin E (for review (24)). Cyclin E is accumu­
lating during G l and peaks at late G l . During G l cyclin E-CDK2 complexes are associated 
with p27, which inhibits the CDK kinase activity (20, 31). Only after p27 degradation (17) 
the Gl/S transition is triggered and cells start DNA synthesis within several hours. Evidence 
exists that p27 is ubiquitinated at the end of Gl which marks this protein for degradation by 
proteasomes (4, 17). 
The 20S proteasome is a large protein complex containing 28 subunits, which are arranged 
in four stacked rings consisting each of 7 subunits (21). This is the catalytic core of a larger 
complex, the 26S proteasome (for review (18)). This 26S proteasome acts in cells in an ATP 
and ubiquitin dependent way (9), and degrades proteins into small peptides. Therefore, ubi­
quitinated cyclin В and p27 are substrates for proteasomes. Although lysosomal degradation 
of ubiquitinated proteins has been described recently (10), this phenomenon may only occur 
when proteins are not accessible for proteasomes, such as membrane proteins, and is not 
likely to occur for cytosol-located proteins. 
Proteasomes exhibit at least three major, distinct proteolytic activities: i.e. trypsin-like, 
chymotrypsin-like and peptidyl glutamyl peptide bond hydrolyzing (PGPH) activity. The 
activities can be inhibited or activated independently and differentially. Several membrane 
permeable peptide protease inhibitors have been described and characterized (22, 25, 33). 
Most of these peptides not only inhibit proteasomes, but also affect the activity of other 
proteases such as calpains and cathepsin В (22). 
C E L L C Y C L E E F F E C T S O F P R O T E A S O M E I N H I B I T I O N 
Although many reports in the literature suggest an active role for proteasomes in cell cycle 
regulation, little is known about the in vivo targets of these proteolytic enzymes. Therefore 
we investigated whether specific inhibition of proteasome activity in living cells would result 
in interference with specific cell cycle phase transitions and if so, which proteolytic activity is 
associated with the observed effects. To this end we used a panel of protease inhibitors which 
display differential inhibitory effects on purified proteasomes, and studied cell cycle progres­
sion in the presence of either of the inhibitors by pulse chase experiments using bromodeoxy-
uridine incorporation. Furthermore, inhibition of the distinct proteolytic activities of 
purified proteasomes, was investigated by the use of specific substrates for each of these 
activities. 
Materials and Methods 
Cell culture 
The established and well characterized human non-small cell lung cancer cell line MR65 
(15) was grown in Eagle's modified minimum essential medium (GIBCO, Paisley, Scotland) 
supplemented with 10 mM Hepes pH 7.6 (GIBCO), 1% (v/v) non-essential amino acids 
(GIBCO), 2 mM glutamine (Serva, Heidelberg, Germany), 50 pg/ml gentamycin (AUV, 
Cuyck, The Netherlands) and 10% (v/v) heat inactivated newborn calf serum (GIBCO). 
MR65 cells grow as adherent monolayers. 
Phase contrast micrographs of cell cultures were taken using an Axiovert 35 M microscope 
(Zeiss, Oberkochen, Germany), equipped with a Nikon camera. For this purpose an Agfapan 
APX25 black-and-white film was used. 
Synthesis of MG115 and MG2M 
N-methoxy, N-methyl amine coupling to norvalin, resulting in the precursor molecule 
MG2M (Fig. 1), and subsequent reduction with lithium aluminum hydride, resulting 
in the peptide aldehyde MG115, was based on a method described by Fehrentz et al (6). 
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Fig. I Molecular structures of the protease inhibitors MG2M and MG 115 
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82 Proteasome purification and activity inhibition assay 
Proteasomes were purified from calf liver. Frozen calf liver tissue was thawed, cut into small 
pieces and washed with buffer containing 20 mM Tris-HCl pH 7.4, 20 mM KCl, 5 mM 
MgCh» 2 mM ß-mercaptoethanol and 1 mM EDTA. Than the tissue was homogenized 
in buffer with 20 mM Tris-HCl pH 7.4, 20 mM KCl, 5 mM MgCl2, 2 mM ß-mercapto-
ethanol, 1 mM EDTA and 200 mM sucrose. The homogenized tissue was filtered, the 
filtrate was homogenized and centrifuged at 10,000 rpm in a Sorvall SA 600 rotor for 30 
minutes at 4°C. The supernatant was centrifuged at 39,000 rpm at 4°C in a Beckmann 
ultracentrifuge using a Ti 50.2 rotor, and the resulting supernatant was loaded on a 30% 
(w/v) sucrose cushion and centrifuged in a Ti 50.2 rotor for 19 hours at 39,000 rpm. The 
pellet was dissolved in buffer containing 20 mM Tris-HCl pH 7.4, 100 mM KCl, 5 mM 
MgCL, 2 mM ß-mercaptoethanol, 1 mM EDTA, loaded on a Sepharose Q fast flow column 
(Pharmacia) and subsequently eluted in three steps with buffer containing (I) 20 mM Tris-
HCl pH 7.4, 300 mM KCL, 2 mM ß-mercaptoethanol, 1 mM EDTA, (II) 20 mM Tris-
HCl pH 7.4, 400 mM KCL, 2 mM ß-mercaptoethanol, 1 mM EDTA, and (III) 20 mM 
Tris-HCl pH 7.4, 1000 mM KCL, 2 mM ß-mercaptoethanol, 1 mM EDTA. Proteasomes 
were recovered form the second elution by addition of sarkosyl (Sigma) until the final 
concentration was 0.2% and subsequent centrifugation in a Ti 50.2 rotor for 19 hours at 
39,000 rpm. Then the pellet was resuspended in 20 mM Tris-HCl pH 7.4, 100 mM KCL, 
2 mM ß-mercaptoethanol, 1 mM EDTA and 0.2% sarkosyl, loaded onto a 5-25% sucrose 
gradient in the same buffer and centrifuged in a SW40 rotor for 19 hours at 39,000 rpm. 
Then proteasomes were recovered by concentration in a 10k microsep (Filtron) followed by 
four subsequent dilutions and concentrations in 20 mM Tris-HCl pH 7.4, 100 mM KCL, 
2 mM ß-mercaptoethanol, 1 mM EDTA. Proteasome concentrations of the samples was 
measured by the Bradford dye-binding assay using BSA as standard. 
The activity of MGl 15 and MG2M treated proteasomes was tested with the following 
synthetic fluorogenic peptide substrates: succinyl-Leu-Leu-Val-Туг-AMC (7-amido-4-methyl-
coumarin, Sigma) for chymotrypsin-like activity, N-benzoyl-Phe-Val-Arg-MNA (4-methoxy-
ß-naphtyl amide, Sigma) for trypsin-like activity and N-carbobenzoxy-Leu-Leu-Glu-ßNA 
(ß-naphtyl amide, Sigma) for PGPH activity. The assays were performed in 200 μΐ reaction 
volumes containing 2 pg of purified proteasomes, 50 mM Tris-HCl pH 8.0, 1 mM 
dithioerythritol (Merck), 1.5% (v/v) DMSO, 50 μΜ fluorogenic protease substrate and 
various concentrations of M G l 15 and MG2M. The reactions were performed at 37°C and 
stopped after 1 hour by adding 300 μΐ 1% (w/v) SDS in 0.1 M sodium borate. Released 
fluorogenic groups were measured in a Hitachi F-3000 spectrofluorometer at the following 
excitation and emission wavelengths: 339 nm and 439 nm for AMC, 333 nm and 413 nm 
for MNA, and 332 nm and 408 nm for ßNA. 
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brdUrd pulse labeling 83 
The cells were pulse labeled by addition of bromodeoxyuridine (BrdUrd, Serva) to the cul­
ture medium in a final concentration of 10 μΜ for 30 minutes. Then the cells were rinsed 
twice with prewarmed 0.15 M phosphate buffered saline (PBS, containing 8 g/1 NaCl, 0.2 
g/1 KCL, 1.15 g/1 N a 2 H P 0 4 and 0.2 g/1 KH2PO4 pH 7.4) and chased in prewarmed culture 
medium supplemented with 5 μΜ deoxythymidine (Serva) and optional one of the protease 
inhibitors (see below). 
Protease inhibitor treatment 
The three protease inhibitors that were used in this study are calpain inhibitor I (Boehringer 
Mannheim GmbH, Mannheim, Germany), calpain inhibitor II (Boehringer Mannheim), 
and MG115. MG2M, the MG115 structural analogue, served as a negative control. The 
inhibitors, dissolved in DMSO, were added to the cell cultures after BrdUrd labeling in 
the following concentrations: 50 μΜ MG2M; 2 μΜ, 11 μΜ and 54 μΜ MGI 15; 45 μΜ 
calpain inhibitor I; and 20 μΜ, 60 μΜ and 180 μΜ calpain inhibitor II. The final concen­
trations of DMSO were below 1.2% (v/v) in all experiments. In control experiments 1.2% 
(v/v) DMSO was added to the culture medium. For harvesting at various time points the 
detached cells were collected by centrifugation of the culture medium and the adherent cells 
were harvested by trypsinization; the two fractions were pooled for analysis. Approximately 
10s cells were fixed in 70% ethanol at -20°C and used for bivariate BrdUrd/DNA flow 
cytometric analysis. The remainder of the cell suspension was centrifuged, the pellet 
«suspended in a small volume of buffer containing 50 mM Tris-HCl pH 7.4, 17% (v/v) 
glycerol and 2 mM ATP, and used for non-denaturing gel electrophoresis. 
Antibodies 
The primary antibodies used in this study were: 1) the mouse monoclonal antibody MCP20 
(8), specific for a 32 kDa proteasome subunit, kindly provided by Dr. K. Hendil (August 
Krogh Institute, University of Copenhagen, DK); 2) a mouse monoclonal anti-BrdUrd 
antibody (culture supernatant clone IIB5; antibody is commercially available from Euro-
Diagnostica B.V., Apeldoorn, The Netherlands); 3) the mouse monoclonal antibody E7, 
specific for tubulin (Developmental Studies Hybridoma Bank, USA ) ; 4) a rabbit polyclonal 
anti-ubiquitin antibody (DAKO A/S, Glostrup, Denmark). 
Immunocytochemistry 
Incorporated BrdUrd was detected as described previously (23). Briefly, approximately 106 
ethanol fixed cells were rinsed with PBS and resuspended in 2 ml of 0.4 mg/ml pepsin 
(Serva) in 0.1 M HCl. After 30 minutes at room temperature cells were pelleted, 
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84 resuspended in 2 M HCl and incubated for another 30 minutes at 37°C. Then the cells were 
rinsed with 0.2 M borate buffer pH 8.5 and PBS containing 0.1% BSA (Sigma, St. Louis, 
MO/USA). The cell pellet was resuspended in 100 μΐ PBS containing 1% BSA and appro­
priately diluted anti-BrdUrd antibody (culture supernatant) was added. After incubation for 
1 hour at room temperature the cells were rinsed twice with PBS containing 1% BSA. Then 
the cell pellet was incubated for 45 minutes at room temperature with FITC-conjugated 
F(ab)2 fragments of rabbit anti-mouse Ig (DAKO A/S, Glostrup, Denmark) diluted 1:10 
in PBS containing 1% BSA. The cells were rinsed twice with PBS containing 1% BSA and 
finally resuspended in 0.5 ml cold PBS containing 100 μg/ml RNase (Serva) and 20 μg/ml 
propidium iodide (PI, Calbiochem, La Jolla, CA/USA). The samples were allowed to 
stand for at least 15 minutes on ice in the dark before flow cytometric analyses were 
performed. 
Flow cytometry 
For flow cytometric analysis a FACSort (Becton Dickinson, Sunnyvale, CA/USA) equipped 
with a single argon laser was used. Exitation was done at 488 nm, and the emission filters 
used were 515-545 BP (green, FITC) and 600 LP (red, PI). A minimum of 10,000 cells per 
sample was recorded and stored in list mode. FITC signals were recorded as logarithmic 
amplified data, while PI signals were recorded as linear amplified data. For bivariate FITC/PI 
analysis no compensation was used. 
Data analysis was performed with the standard Lysis software (Becton Dickinson). As a 
standard procedure for all analyses, data were gated on pulse processed PI signals to exclude 
doublets and larger aggregates. 
For detailed cell kinetic analysis, five cell cycle compartments were identified as described by 
Higashikubo et al. (11). The following populations were identified (Fig. 2): 
1. BrdUrd positive undivided cells (Lu) 2. BrdUrd positive divided cells (Ld) 3. BrdUrd 
negative G2/M cells (G2/M-) 4. BrdUrd negative G l cells (G1-) 5. BrdUrd negative Gl and 
S cells (G1S-) From these populations three parameters reflecting cell cycle progression were 
determined: 
1) relative movement (1), mean DNA content of the BrdUrd positive undivided population 
normalized to G l and G2/M position RM = (XLU-XGI)/ (Хсг/М-Хсі); 
2) BrdUrd negative G2/M fraction FG:/M- = NG2/M-/NT ; 
3) the position of negative cells excluding the initial G2/M cells normalized to G l and 
G2/M position X- = (XGis-'XcO/iXGa/M-Xd); 
where X denotes the mean DNA content of the population indicated in the subscript, 
N is the number of cells in the population indicated in the subscript and Τ is the total 
cell population. 
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Fig. 2 Flow cytogram of a 
bivariate BrdUrd/DNA analysis 
of MR65 cells, showing DNA 
content (abscissa) versus BrdUrd 
immunofluorescence (ordinate). 
The cells were pulse labeled 
with BrdUrd and chased for 
three hours in culture medium. 
Five populations (1-5) were 
identified in which absolute cell 
numbers or the mean DNA 
content of the cell fraction was 
estimated. 
—& 
DNA content 
Data analysis 
The parameters were plotted as a function of time after BrdUrd pulse labeling. 
To quantitatively assess cell cycle progression, linear portions of the kinetic curves were fitted 
by linear regression analysis. For the BrdUrd negative G2/M fractions the linear regression 
analysis was performed on logarithmically transformed data. The slopes of the regression 
lines were used to calculate changes in rates of cell cycle progression. 
Gel electrophoresis and immunoblotting 
For non-denaturing gel electrophoresis cell samples were resuspended in 50 mM Tris-HCl 
pH 7.4 containing 17% glycerol and 2 mM ATP, and sonicated for 5 seconds at 0°C. For 
non-denaturing stacking gels 3.5% acrylamide was dissolved in 125 mM Tris-HCl pH 6.8, 
0.1 mM EDTA and 1.6 mM N a ^ O - and for non-denaturing resolving gels 4.5% 
acrylamide was dissolved in 375 mM Tris-HCl pH 8.8, 0.1 mM EDTA and 1.6 mM 
Na2B407 . Samples were electrophoresed at 10 mA per gel for 60 minutes in precooled (4°C) 
buffer containing 25 mM Tris and 192 mM glycine pH 8.3. Electrophoresis was performed 
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86 at 4°C in the Mini-Protean II system (Bio-Rad Laboratories, Hercules, CA/USA). Immuno-
blotting was performed according to the method of Towbin et al (30) using nitrocellulose 
membranes (Schleicher and Schuell, Dassel, Germany). The blots were incubated with 
primary antibody, washed with PBS and subsequently antibody binding was detected with 
either a secondary, alkaline phosphatase-conjugated rabbit anti-mouse Ig antibody (DAKO 
A/S), a peroxidase-conjugated rabbit anti-mouse Ig antibody (DAKO A/S), an alkaline phos­
phatase-conjugated swine anti-rabbit Ig antibody (DAKO A/S), or a peroxidase-conjugated 
swine anti-rabbit Ig antibody (DAKO A/S). Alkaline phosphatase reactivity was detected 
by incubation with 0.41 mM nitro blue tetrazolium (Sigma) and 0.45 mM 5-bromo-4-
chloro-3-indolyl phosphate (Sigma); peroxidase reactivity was detected by enhanced chemi-
luminescence (ECL-kit, Amersham, Buckinghamshire, UK) as previously described (16). 
For denaturing gel electrophoresis samples were boiled for 5 minutes in SDS-sample buffer 
and loaded onto denaturing Polyacrylamide gels (14) containing 10% Polyacrylamide. Gels 
were run on the Mini-Protean II system (Bio-Rad Laboratories) for approximately 45 
minutes at 200 V. Blotting and staining of the blots was performed as described above 
for non-denaturing gels. 
Substrate overlay assay 
Chymotrypsin-like protease activity was detected in non-denaturing gels by overlay with 200 
μΜ of the fluorogenic substrate succinyl-Leu-Leu-Val-Tyr-AMC (Calbiochem-Novabiochem, 
Bad Soden/Ts, Germany) in 30 mM Tris-HCl pH 7.8, 5 mM MgCl2 ) 10 mM KCL, 2 mM 
ATP and 0.1% (w/v) sodium dodecyl sulphate (SDS). The gels were incubated for 45-60 
minutes at 37°C and then transluminated with UV light to visualize the proteolytically 
cleaved, fluorescent product and photographed with a Polaroid camera using a 440 nm filter. 
Results 
Effect of proteasome inhibition on cell cycle progression 
MG115, calpain inhibitor I and calpain inhibitor II are membrane permeable protease 
inhibitors. By addition of the inhibitors to the culture medium of cells we were able to 
study their effects on cell growth and proliferation. Additionally, the effects of MG2M, 
a compound that is structurally related to MG 115, were studied. 
When MG115 was added to the culture medium of MR65 cells, accumulation of cells in 
metaphase was seen (Fig. 3a,b), and, in contrast to untreated cultures, no anaphase cells 
were seen. Accumulation of cells in metaphase was not seen in cultures treated with calpain 
inhibitors I and II or with MG2M. 
Proteasome localization in MG115 treated cultures was identical to proteasome localization 
in untreated cultures (16), as determined by immunostaining with the anti-proteasome 
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Fig. 3 Phase contrast micrographs of 
(a) a control MR65 culture and (b) a 
MR65 culture that has been treated 
for 4 hours with 54 μΜ MG I 15. 
Immunofluorescence micrographs 
of a MR65 culture that had been 
treated with MG I 15 for 4 hours, 
(c) stained with the anti-proteasome 
antibody MCP20 and (d ) with the 
anti-tubulin antibody E7. Note that 
the spindles appear normal in 
metaphase cells. Bars indicate 10 μιτι. 
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antibody MCP20 (Fig. 3c). Furthermore, mitotic spindles 
appeared normal in MG 115 treated cultures, as deter­
mined by immunostaining with anti-tubulin antibody E7 
(Fig. 3d). 
More detailed cell kinetic analysis was performed with 
BrdUrd labeled cells using flow cytometry. The results 
were processed as described previously by Higashikubo 
(11). In Fig. 4a-c the results of treatment with three 
concentrations MG115 are shown. When MG115 was 
added to a concentration of 54 μΜ, the transition of G l 
cells to S phase and their subsequent movement through 
S phase (designated as X- in materials and methods) was 
blocked (Fig. 4a). At lower concentrations of MG115 the 
cells were not completely blocked at Gl/S transition, but 
their exit rate from G l was decreased in a concentration 
dependent manner. The relative movement of BrdUrd 
labeled cells through S phase (designated as RM in 
materials and methods) was not completely blocked at 
the highest concentration, but it was decreased in a dose 
dependent manner (Fig. 4b). For the G2/M transition 
(designated as FG2M in materials and methods) the same 
holds true as for Gl/S transition, in that it was 
completely blocked when cells were treated with 
54 μΜ MGI 15, while at lower concentrations the 
M-phase exit rate was decreased (Fig. 4c). 
In contrast, addition of MG2M showed little or no effect 
on cell cycle progression, despite high concentrations up 
to 50 μΜ (Fig. 4d,e,f ). The Gl/S transition (X-) and the 
Fig. 4 The effect of various doses MG 115 (a.b.c), MG2M 
(d,e,f) and calpain inhibitor I and II (g,h,i) on cell cycle kinetics 
of MR65 cells are depicted as a function of time in the 
presence of the inhibitor.The Gl/S transition (X- in a,d,g) 
relative movement through S phase (RM in b,e,h) and the 
fraction of G2/M negative cells (FG2M- ¡n c,f,i) are shown. 
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90 progression through mitosis (FG2M-) were only slightly decreased, and the relative movement 
through S phase (RM) was unaffected as compared to control cultures. 
Calpain inhibitor I and calpain inhibitor II are known to exhibit differential inhibitory 
effects on purified proteasomes (22) and this appeared to be also the case in living cells. 
The results are shown in Fig. 4g,h,i. For calpain inhibitor II no effects on the cell cycle 
progression were detected when applied in a concentration of 60 pM or 180 pM. 
In contrast, 45 pM of calpain inhibitor I had an effect. The Gl /S transition (X-) and 
progression through mitosis (FG2M) were decreased by approximately 80%, the relative 
movement through S phase (RM) was decreased by approximately 55% as compared to 
untreated cultures. In general, the effect of calpain inhibitor I was comparable to the 
effect of a 5 fold lower MG115 concentration. 
Reversibility ofMGI IS inhibition 
Reversibility of the cell cycle effects of MG115 was tested by treating MR65 cell cultures 
with 54 uM MG115 as described above. After 7 hours of incubation the MG115 containing 
culture medium was replaced by fresh culture medium without inhibitor. Both during the 
protease inhibition phase and after removal of the inhibitor, samples were analyzed by flow 
cytometry. Fig. 5 shows that after withdrawal of MG115 from the medium the metaphase 
and Gl/S transition blocks were abolished and the cell cycle was immediately resumed. Flow 
cytometric analysis of the released cultures (Fig. 5a-c) showed that BrdUrd unlabeled cells 
started progression through S phase as soon as the drug was washed out, indicating that the 
block on Gl/S transition must had been removed. Furthermore, the fraction of unlabeled 
G2/M cells decreased, indicating that the metaphase block had been removed as well. The 
DNA histograms of the culture several hours after withdrawal of MG115 showed a small 
peak of synchronized cells moving through S phase (Fig. 5d-f)- This indicated that the cells, 
while treated with the inhibitor, were not blocked throughout all stages of G l , but had 
moved through Gl and were blocked only at a defined point at the end of G l or at the 
Gl/S transition. 
Proteasome content and protease activity of inhibited cell cultures 
Samples of inhibitor treated cell cultures were used for non-denaturing gel electrophoresis 
and subsequent immunoblotting or substrate overlay assays. Immunoblotting of samples of 
untreated cultures and cultures that were treated with 54 pM MG115 for 1.5 or 6 hours 
showed that 20S proteasomes were present in all samples (Fig. 6, panel A lanes 1,2,3). 
However, when an identical gel was used in a substrate overlay assay the chymotrypsin-like 
activity of the 20S proteasomes was largely decreased in samples of MG115 treated cultures 
compared to samples of untreated cultures (Fig. 6, panel A lanes 4,5,6). In cultures that were 
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Fig. 5 Dot plots, showing DNA content (abscissa) versus BrdUrd 
fluorescence (ordinate), of initially MG I 15 treated MR65 cultures (a) 
immediately after withdrawal of MG I 15, (b) 3.5 hours after withdrawal, 
and (c) 5.5 hours after withdrawal. The cell cycle is resumed since 
unlabeled cells start moving through S phase, the fraction of BrdUrd 
negative G2/M phase cells decreases and BrdUrd positive Gl phase 
cells appear.The DNA histograms of MR65 cultures (d ) immediately 
after withdrawal of the drug, (e) 3.5 hours after withdrawal and (f) 5.5 
hours after withdrawal are shown. A small peak of synchronized cells 
moves through S phase after 3.5 and 5.5 hours. 
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treated with 10 μΜ MGI 15 a similar inhibitory effect of the chymotrypsin-like activity was 
seen, while 2 μΜ MGI 15 did not inhibit chymotrypsin-like activity of 20S proteasomes 
(results not shown). 
Furthermore, immunoblotting of denaturing gels showed that the samples of MG 115 treated 
cell cultures contained considerably more ubiquitinated proteins compared to untreated 
cultures (Fig. 6, panel В lanes 1,2,3). 
·
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Fig. 6 Panel A: Immunoblotting of a non-denaturing Polyacrylamide gel, 
showing the detection of 20S proteasomes with antibody MCP20 in samples 
of untreated MR65 cells (lane I), after 1.5 hours of MG 115 treatment (lane 
2) and after 6 hours of MG I 15 treatment (lane 3). Proteolytic activity of the 
20S proteasomes in an identical non-denaturing gel was measured in samples 
of untreated MR.65 cells (lane 4), after 1.5 hours of MG I 15 treatment (lane 
5) and after 6 hours of MG I 15 treatment (lane 6). Panel B: Immunoblotting 
of a denaturing Polyacrylamide gel, showing the detection of ubiquitinated 
proteins with the polyclonal anti-ubiquitin antibody in samples of untreated 
MR65 cells (lane I) and MR65 cells that were treated with MG I 15 for 2 
hours (lane 2) and 6 hours (lane 3). 
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Effects ofMG2M and MG 115 on purified proteasomes 
Additionally, the inhibitory effects of MG 115 or MG2M on chymotrypsin-hke, trypsin-hke 
and PGPH activities of isolated 20S proteasomes were tested The results of these 
experiments are presented in Fig 7a,b MG115 appeared to be a very potent inhibitor of the 
trypsin- and chymotrypsin-hke activities of the 20S proteasomes, resulting in activity 
inhibition of approximately 90% when MG115 concentrations of 1 uM and 10 μΜ were 
used The PGPH activity was less effectively inhibited and dropped only below 20% of the 
93 
1 0 0 
g 4 0 -
β— trypsin 
«— PGPH 
-o— chymoirypsin 
ι ι ι ι π ι 
1 10 
ΜΟΙΙ5ιημΜ 
1 0 0 
• 
Й? 1 0 0 - i 
a
c
tiv
ity
 
in
 
о
 
о
 
ι
 
.
 
.
 
ω 
I 40~ "ω 
2 0 : b 
' 
- B — trypsin 
-Θ— PGPH 
» MG2M chymotrypsm 
η 1 1 1 
1 10 
MG2M in μΜ 
—ι—г—г-Γττη 
100 
Fig. 7 The relative activity 
(activity of proteasomes with 
inhibitor/activity of protea-
some without inhibitor χ 
100%) of purified bovine 
proteasomes was determined 
in duplo and plotted as a 
function of the concentration 
o f M G I I 5 ( a ) o r M G 2 M ( b ) 
Since the initial trypsin-hke 
activity of 20S proteasomes 
without inhibitor was low, 
small changes in absolute 
activity resulted in large 
changes in relative activity 
The relative progression rates 
of a MG 115 treated cell 
culture (progression rate with 
inhibitor/progression rate 
without inhibitor χ 100%) 
through GI /S transition, 
S phase and G2/M transition 
(c) was plotted as a function 
of concentration MG 115 
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94 initial activity when very high concentrations of M G l 15 were used. The precursor MG2M 
did only slightly affect (an inhibition of approximately 10%) the proteasome activities. 
Even when 100 μΜ of MG2M was used, the remaining proteasomal activity was still 
approximately 90% ofthat of untreated proteasomes. 
Intracellular concentration of MGl 15 
The intracellular concentration of M G l 15 may differ from the concentration in the culture 
medium. To obtain an impression about the intracellular concentration of M G l 15, the 
results of the substrate overlay assay and the in vitro inhibition assay were compared. 
The in vitro inhibition assay showed that 5 μΜ M G l 15 inhibited more than 80% of the 
chymotrypsin-like activity of proteasomes. The substrate overlay assay showed that a 
concentration of 10 μΜ in the culture medium was sufficient for intracellular inhibition 
of the chymotrypsin-like activity. Therefore, the intracellular M G l 15 concentration must 
have been above 5 μΜ, which is the minimal concentration that is necessary for maximal 
chymotrypsin-like activity inhibition. In conclusion, these consideration indicate that the 
intracellular concentration of M G l 15 may be only slightly lower than the extracellular 
concentration. 
Comparison of in vitro and in vivo effects of MGl 15 on proteasome activity 
In order to correlate the experiments in cultured cells to the in vitro inhibition experiments 
using purified proteasomes, the relative progression rates (progression rate with 
inhibitor/progression rate without inhibitor χ 100%) through Gl/S and G2/M of M G l 15 
treated cell cultures were determined by the slopes of the curves in Fig. 4a,b,c and plotted as 
a function of MG 115 concentration in the culture medium in Fig. 7c. Since the intracellular 
concentration of M G l 15 is approximately the inhibitor concentration applied in the culture 
medium, in vivo cell cycle effects can be compared to in vitro inhibition effects. 
Chymotrypsin-like activity is most likely to be involved in cell cycle progression. When 
added in low concentrations moderate effects were detected on purified proteasomes and 
intracellular proteasomes, but when concentrations above 11 μΜ were applied to the culture 
medium the proteasomal chymotrypsin-like activity is almost completely blocked and major 
cell cycle effects are detected. 
Since PGPH activity is only slightly inhibited when purified proteasomes were treated with 
10 μΜ M G l 15 (Fig. 7b), this activity cannot be responsible for the major effects that were 
seen in cell cycle progression when using 11 μΜ in the culture medium. 
Trypsin-like activity of purified proteasomes was almost completely inhibited by 1 μΜ 
M G l 15, but when 2 μΜ of M G l 15 was added to the culture medium no effect was found 
on G2/M and S-phase progression and a slight effect was seen on Gl/S transition, suggesting 
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a marginal effect of trypsin-like activity in the cell cycle. However, involvement of trypsin- 95 
like activity cannot be completely excluded. The initial level of trypsin-like activity in the 
in vitro inhibition experiments was low, and low initial trypsin-like activity implicates that 
small changes in absolute activity lead to large changes in relative activity. Therefore, the 
activity measurements are inaccurate, and the involvement of trypsin-like activity may be 
underestimated. 
Discussion 
Studies upon the involvement of proteasome activity in cell cycle progression can be based 
on distinct approaches. For instance, proteasome activity at specific points in the cell cycle 
can be studied. Results of such studies indicated that proteasomes are activated periodically 
during metaphase of both the mitotic and meiotic division cycle (12, 13). In another 
approach proteasome activity may be inhibited, and subsequent effects may be ascribed to 
the inhibited protease (25). The conclusions of such studies are often compromised by the 
specificity of the inhibitors. In our investigations we used a set of well characterized cell 
membrane-permeable protease inhibitors that have differential inhibitory effects on isolated 
20S and 26S proteasomes, but equal inhibitory effects on calpain and cathepsin В (22, 33). 
BrdUrd pulse labeling allowed to study cell progression through various compartments of 
the cell cycle, either in inhibitor treated cultures or in untreated cultures. 
Addition of calpain inhibitor I, calpain inhibitor II or MG115 to the culture medium of 
cells had different effects on cell cycle kinetics, in that calpain inhibitor II had no effect on 
cell cycle progression, MG115 could block the cell cycle almost completely, and calpain 
inhibitor I had an intermediate effect. Since the three inhibitors have biochemically similar 
inhibitory effects on cathepsin В and calpain (22), but differential inhibitory effects on 
proteasomes, it is plausible that the changes in cell kinetics that we detected in our in vitro 
studies are due to proteasome inhibition and not calpain or cathepsin В inhibition. 
Additional evidence for proteasome inhibition by MG115 was obtained from native gel-
electrophoresis and subsequent activity assays and immunoblottings, since proteasomes were 
present in almost unchanged levels in samples of either inhibitor treated and untreated 
cultures, but were not proteolytically active in samples of MG115 treated cultures. Moreover, 
ubiquitinated proteins accumulated in MG115 treated cells, confirming again absence of 
proteasomal activity. 
The changes in cell cycle kinetics upon addition of MG115, e.g. blocks in metaphase and at 
the Gl/S transition, were strikingly concordant with previously reported time-points of 
ubiquitin dependent degradation of cyclin В (7) and p27 (17). However, involvement of 
other proteins that act in a ubiquitin or proteasome dependent way can not be excluded. 
Recently, several other proteins that are ubiquitin-dependent degraded in metaphase-
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anaphase transition have been described (2, 19, 27). Such proteins may additionally be 
responsible for the metaphase block that was detected in MG 115 treated cells. 
Next to the Gl /S and metaphase blocks that were observed, a slow S phase progression was 
seen. A cyclin A-CDK2 complex is necessary for progression through S phase, and has been 
described to be localized with the sites of DNA replication during S phase (3, 17, 26). 
Probably, cyclin A-CDK2 activity is regulated by other proteins which function is 
proteasome dependent. Inhibition of the proteolytic degradation of cyclin A is not a likely 
explanation for the observed decrease in S-phase progression rate, since cyclin A is only 
degraded at the end of G2/M phase (5, 28). Alternatively, Vassilev et al. (32) have shown 
that ubiquitination of histones takes place in S-phase cells, which is an indication for 
involvement of proteasomal activity during S-phase. Blocking of this activity by MG115 may 
be responsible for the decrease in S phase progression rate that was found, due to improper 
unwinding of the DNA and disturbed formation of the replication fork. A third possibility 
is that MG115 treatment of cells leads to unscheduled expression of cyclins, which leads to 
growth perturbations (5), but presendy the nature and effects of unscheduled cyclin 
expression are not yet well understood. 
In otder to clarify the contribution of each of the individual proteolytic activities of the 
proteasome to cell cycle progression, relative activity profiles were calculated from 
biochemical activity measurements, which were compared to relative progression rates 
calculated from in vitro measurements. The relative activity profiles for chymotrypsin-like 
activity of purified proteasomes resemble most closely the relative progression rate profiles 
of cell cultures when treated with the proteasome inhibitor MG115. Trypsin-like activity of 
purified proteasomes is strongly inhibited in the presence of low concentrations of MG 115, 
but the effect on cell cycle progression was minimal when such low concentrations were 
applied to cell cultures. This was not due to a difference between intracellular and 
extracellular inhibitor concentrations, since the intracellular concentrations of MG115 
were only slightly lower than the concentrations in the culture medium. Therefore, a 
stronger effect on cell cycle progression through inhibition of trypsin-like activity would be 
expected with low concentrations of MG 115, if this activity would be crucial for cell cycle 
progression. Additionally, involvement of PGPH activity in cell cycle progression was 
considered little since the inhibitory effect of MG115 on PGPH activity of purified 
proteasomes did not parallel the inhibitory effect of MG115 on cell cycle progression. 
Considering these results, chymotrypsin-like activity of the proteasome might be regarded 
as the most important of the three proteasomal activities in cell cycle progression. However, 
it should be kept in mind that the biochemical data were obtained with artificial substrates 
which may not entirely reflect the activity to entirely different in vivo substrates, and that 
proper functioning of the proteasome may require more then one activity at a time. 
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Summary 
C H A P T E R 6 
One of the major protein degradation mechanisms in the living cell is the proteasome-
ubiquitin-pathway. It is not only involved in general protein turnover but also in the highly 
regulated degradation of key proteins. Targets of the proteasome-ubiquitin-pathway include 
key regulators, which control a variety of important cellular processes, like metabolic 
pathways, immune and inflammatory response, apoptosis and cell cycle. 
The system marks proteins for degradation by covalent linkage of multiple copies of the 
small conserved polypeptide ubiquitin. Polyubiquitinated proteins are subsequently degraded 
by the 26S proteasome. This large complex consists of the barrel-shaped 20S proteasome, at 
its ends flanked by 19S regulatory complexes. The inner chamber of the 20S proteasome 
harbors the proteolytic sites, whereas, the 19S regulatory complexes control entrance of 
proteins, confer ubiquitin binding and energy generation. In this thesis a molecular biological 
approach is described to elucidate the role of proteasomes in cell cycle progression and to get 
insight into the structure and assembly of the human 20S proteasome. 
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102 Chapter 1 provides a general introduction in which our present knowledge concerning 
proteasome function, proteolytic activity, structure and assembly is reviewed. 
The eukaryotic 20S proteasome is built of four rings, each ring containing seven different 
subunits, located at fixed positions. The outer and inner rings contain a- and ß-type 
subunits, respectively. The assembly of this complex oligomeric particle has to occur in a 
highly coordinated way. Insight into the assembly process of a particle can be obtained by 
isolating and characterizing assembly intermediates. However, using such an approach, 
only two different assembly intermediates have been described recently, 13S (probably 
half-proteasomes) and 16S complexes (probably immature dimerized 13S complexes), 
which both represent complexes late in proteasome assembly. The current eukaryotic 
assembly model, which is in part based on the discovery of these intermediates and on data 
from archaebacterial proteasome assembly, includes four steps: (1) formation of an α-ring 
complex; (2) assembly of ß-type subunits onto the α-ring, resulting in a half-proteasome 
(13S complex); (3) dimerization of two half-proteasomes (16S intermediate); (4) maturation 
into a functional proteasome (e.g. ß-subunit processing). In this thesis a different approach is 
described to get insight into early proteasome assembly. A recombinant production system 
was used to study the assembly properties of single or combinations of human subunits. 
Such a system had previously been used to study the assembly of the proteasome of the 
archaebacterium Thermoplasma acidophilum (Ta). The T. acidophilum proteasome consists 
of only multiple copies of two different subunits, α and ß. Coexpression of the Ta-α- and 
Ta-ß-subunit in E. ¿»/¿yielded functional proteasome particles. Single expression of Ta-α 
resulted in double-ring structures, whereas Ta-ß formed monomers. 
In chapter 2 the cloning of a cDNA encoding the human ß-type subunit HsBPROS26 is 
described. This cDNA was isolated by screening a human cDNA library with a probe 
encoding the Xenopus laevis homologue of HsBPROS26 (XLB). Expression of HsBPROS26 
resulted in a monomeric protein containing no detectible proteolytic activity. In chapter 3 
this study is extended with the α-type subunit HsC8. Interestingly, the HsC8 protein formed 
large complexes upon recombinant production. Electron microscopical analysis with the help 
of digital image processing of these complexes revealed that HsC8 assembles by itself into 
double heptameric ring structures, which closely resemble recombinant Ta-α complexes. This 
was surprising, since accumulating evidence indicates that in the eukaryotic proteasome only 
one HsC8 subunit is present in each α-ring and that this subunit has two different defined 
neighbor subunits. Since in T. acidophilum proteasome assembly the Ta-α rings have a 
function in folding, processing and assembly of the Ta-ß-subunit it was tested whether HsC8 
has a similar function in human proteasome assembly. As human ß-type subunits were used 
mature-like HsDelta, precursor HsBPROS26 and its mature form, HsBPROS26mat, which in 
the human proteasome contact HsC8 (see general introduction Fig. 2). All three ß-type 
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subunits did not form ring complexes upon single recombinant expression, but existed in 103 
monomeric up to tetrameric form. In contrast to the a- and ß-subunit of T. acidophilum, 
coexpression of HsC8 with these ß-type subunits did not yield functional proteasome-like 
particles. These results suggest that proteasome-like particles consisting of only two human 
subunits probably cannot be constructed, which would be in agreement with the notion 
that proteasome assembly in eukaryotes is much more complex than in archaebacteria. 
The role of HsC8 in the assembly process, apparently, is different from that of the 
T. acidophilum a-subunit, since HsC8 does not form 20S complexes with recombinant 
human ß-subunits. Therefore, in chapter 4 is dealt with the question whether HsC8 has a 
role in the assembly of different α-type subunits into the ring complex. The human a-type 
subunits HsPROS30 and HsPROS27 were used, which in the native proteasome both are 
neighbor subunits of HsC8 (see general introduction Fig. 2). In chapter 4 it is shown first 
that the ability of HsC8 to assemble into rings is not a general feature of human a-type 
subunits. Both HsPROS30 and HsPROS27 formed dimers. To test the hypothesis that 
HsC8 is important for α-ring formation, possibly by functioning as a scaffold structure to 
which other α-type subunits can join, HsC8 was coexpressed with HsPROS30 or HsPROS27. 
This resulted with both subunits in the formation of hetero-oligomeric ring complexes, 
resembling the HsC8 ringlike structure. Thus, HsC8 can help at least its natural neighboring 
subunits to assemble into ring structures. The ratio between the two types of subunits in the 
mixed complexes, fractionated on a Sepharose Q anion-exchange column, was surprisingly 
heterogeneous, varying between a very high and very low HsC8 content. It was concluded 
that the α-type subunits apparently lack binding sites that selectively interact with a specific 
neighboring α-type subunit. This suggests that the correct positioning of the seven different 
α-type subunits in the eukaryotic 20S proteasome is most probably not dictated by the 
α-type subunits themselves, but may rather be determined by the interaction with specific 
ß-type subunits. Very recendy, this hypothesis was supported by the elucidation of the yeast 
proteasomal crystal structure, which revealed that some α-β and β-β contacts are very 
specific. Summarizing, it was conjectured that steps (1) and (2) of the above described 
eukaryotic proteasome assembly model occur simultaneously and that the ß-type subunits 
are involved early in correct positioning of the α-type subunits. In the eukaryotic assembly 
process, the HsC8 subunit might have an important function in initiating a very early step 
of the ring formation. 
In chapter 5 the role of the proteasome in cell cycle progression is investigated. Four peptide 
inhibitors were used which display differential inhibitory effects on proteasomes in vitro, as 
shown in part in chapter 5. Cell kinetic studies using bromodeoxyuridine pulse labeling 
revealed that the proteasome inhibitor MG115 blocked Gl-S and metaphase transitions 
and delayed progression through S-phase. The effect of the three other inhibitors was 
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104 proportional to their capacity to inhibit proteasomal protease activity in vitro. 
Furthermore, MG 115 inhibition was reversible. It was demonstrated that the proteasomal 
activity of MG115-treated cells was indeed blocked and that these cells contained elevated 
levels of ubiquitinated proteins, confirming that ubiquitin-dependent degradation was 
inhibited. Comparing the in vivo cell cycle effects with in vitro inhibition by MG 115 
it was hypothized that the chymotrypsin-like activity of proteasomes is important for cell 
cycle progression and probably for ubiquitin-dependent protein degradation in general. 
Samenvatting 
C H A P T E R 7 
Eén van de belangrijkste eiwit-degradatie-systemen in de levende cel is de proteasoom-
ubiquitine-route. Deze is niet alleen betrokken bij de algemene eiwitafbraak, maar ook bij 
de sterk gereguleerde degradatie van belangrijke sleuteleiwitten. Tot de doelwitten van het 
proteasoom-ubiquitine-systeem behoren essentiële regulerende eiwitten die belangrijke 
cellulaire processen sturen, zoals metabole routes, immuun- en ontstekingsreacties, 
geprogrammeerde celdood (apoptose) en de celcyclus. Het systeem markeert eiwitten voor 
degradatie door er covalent het polypeptide ubiquitine aan te binden. Polygeübiquitineerde 
eiwitten worden vervolgens herkend en afgebroken door het 26S proteasoom. Dit grote 
enzymcomplex is opgebouwd uit een cilindrisch 20S proteasoom dat aan beide zijden 
geflankeerd wordt door 19S regulerende complexen. De holte in de 20S proteasomen bevat 
de proteolytische centra, terwijl de 19S complexen de toegang van substraten controleren 
en zorgen voor polyubiquitine-binding en ATP-hydrolyse. In dit proefschrift wordt een 
moleculair-biologisch onderzoek beschreven met als doel inzicht te verkrijgen in de rol van 
proteasomen in de celcyclus en de structuur en assemblage van het humane 20S proteasoom. 
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106 Hoofdstuk 1 bevat een algemene inleiding, waarin de huidige kennis over de functies, 
proteolytische activiteit, structuur en assemblage van proteasomen is samengevat. Het 
eukaryotische 20S proteasoom is opgebouwd uit vier ringen, die elk zeven verschillende 
subeenheden op een vaste plaats bevatten. De buitenste en binnenste ringen bevatten 
respectievelijk α- en ß-type subeenheden. De assemblage van dit ingewikkelde multi-
subeenheid-complex moet op een geordende manier plaatsvinden. Inzicht in het assemblage-
mechanisme kan worden verkregen door assemblage-intermediairen te isoleren en te karak-
teriseren. Echter, met een dergelijke benadering zijn tot nu toe maar twee velschillende 
assemblage-intermediairen geïsoleerd: 13S- (mogelijk halve proteasomen) en 16S-complexen 
(waarschijnlijk nog niet rijpe gedimeriscerde 13S-compIexen), die beide pas laat in de 
proteasoom-assemblage-route voorkomen. Het huidige proteasoom-assemblage-model, dat 
gedeeltelijk gebaseerd is op de ontdekking van de assemblage-intetmediairen en kennis van 
de assemblage van het archaebacterië'le proteasoom, omvat 4 stappen: (1) vorming van een 
a-ringcomplex; (2) assemblage van ß-type subeenheden op de α-ring, waardoor een half-
proteasoom ontstaat (13S-complex); (3) dimerisatie van twee halve proteasomen (16S-
complex); (4) maturatie tot functionele en actieve proteasomen (onder andere door de pro­
teolytische klieving van ß-type subeenheden). In dit proefschrift wordt een andere manier 
beschreven om inzicht te verkrijgen in vroege processen van de proteasoom-assemblage. 
Er is gebruik gemaakt van recombinante subeenheden om de assemblage-eigenschappen van 
afzonderlijke of combinaties van twee humane subeenheden te bestuderen. Een vergelijkbaar 
systeem is eerder ook gebruikt om de assemblage van het proteasoom van de archaebacterie 
Thermoplasma acidophilum (Ta) te bestuderen. Het proteasoom van T. acidophilum bestaat 
uit 2x14 kopieën van maar twee verschillende subeenheden, α en β. Coexpressie van de 
Ta-α- en Та-ß-subeenheden in E. coli resulteerde in functionele proteasoom-partikels. 
Afzonderlijk geproduceerd Ta-α vormde dubbele ringstructuren, terwijl Та-ß bestond uit 
monomeren. 
In hoofdstuk 2 wordt de clonering van een cDNA coderend voor de humane ß-type sub-
eenheid HsBPROS26 beschreven. Dit cDNA werd geïsoleerd door het screenen van een 
humane cDNA-bank met een cDNA-probe die codeert voor de Xenopus laevis (klauwpad) 
homoloog van HsBPROS26 (XLB). Expressie van HsBPROS26 resulteerde in een mono-
meer eiwit zonder aantoonbare proteolytische activiteit. In hoofdstuk 3 wordt de assemblage-
studie uitgebreid met de α-type subeenheid HsC8. Het recombinant HsC8-eiwit vormde 
onverwacht grote complexen. Uit analyse met de elektronenmicroscoop en digitale 
beeldverwerking bleek dat HsC8 zelf assembleert tot dubbele ringcomplexen met zeven 
subeenheden in elke ring. Deze complexen hadden vrijwel dezelfde structuur als de 
recombinant Ta-a-complexen. Dit was verrassend, omdat in eukaryotische proteasomen 
HsC8 maar één keer voorkomt in elke α-ring en daarbij twee verschillende buur-
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subeenheden heeft. Aangezien voor T. acidophilum proteasoom-assemblage de α-ringen 107 
belangrijk zijn voor de vouwing, activering en assemblage van de Ta-ß-subeenheden, werd 
getest of HsC8 een vergelijkbare functie heeft in the assemblage van humane proteasomen. 
Als humane ß-rype subeenheden werden HsBPROS26 en HsDelta gebruikt. Deze sub-
eenheden maken contact met HsC8 in het humane proteasoom (zie "general introduction" 
figuur 2). Geen van de geteste ß-type subeenheden vormde ringcomplexen maar ze kwamen 
voor als monomeren tot tetrameren. In tegenstelling tot de α- en ß-subeenheid van 
T. acidophilum, resulteerde de coexpressie van HsC8 met de ß-type subeenheden niet in 
functionele proteasoom-partikels. Deze resultaten suggereren dat proteasoom-achtige 
complexen, die maar uit twee soorten humane subeenheden bestaan, waarschijnlijk niet 
geproduceerd kunnen worden. Dit komt overeen met de veronderstelling dat de proteasoom-
assemblage in eukaryoten veel complexer is dan in archaebacteriën. 
De rol van HsC8 in het assemblage-proces lijkt dus anders dan die van de T. acidophilum a-
type subeenheid, aangezien HsC8 geen 20S-complexen vormt met recombinant ß-type 
subeenheden. Daarom wordt in hoofdstuk 4 bekeken of HsC8 een rol vervult bij de 
assemblage van verschillende α-type subeenheden tot een hetero-oligomeer a-ringcomplex. 
De humane α-type subeenheden HsPROS30 en HsPROS27 werden gebruikt. Deze zijn 
in het humane proteasoom beide buren van HsC8 (zie "general introduction" figuur 2). 
In hoofdstuk 4 wordt eerst aangetoond dat de eigenschap van HsC8 om zelf ringen te 
vormen geen algemeen kenmerk is van humane α-type subeenheden. Zowel HsPROS30 
als HsPROS27 vormen dimeren. Om de hypothese te testen dat HsC8 belangrijk is voor 
de vorming van de complexe humane α-ring, mogelijk door te functioneren als een matrijs 
waarop andere α-type subeenheden kunnen binden, is HsC8 geproduceerd tegelijkertijd met 
HsPROS30 of HsPROS27. Beide subeenheden bleken samen met HsC8 hetero-oligomere 
ringcomplexen te vormen met een op HsC8 gelijkende structuur. Dus HsC8 kan in elk geval 
zijn buren helpen om te assembleren tot ringstructuren. De fractie HsC8 in gemengde 
complexen, gescheiden op een Sepharose Q anionen-wisselaar, bleek sterk te variëren van 
ongeveer 1/7 tot 7/7. Uit deze resultaten wordt geconcludeerd dat de α-type subeenheden 
blijkbaar geen specifieke bindingsplaatsen bevatten die uitsluitend een interactie aangaan 
met een bepaalde buur-subeenheid. Dit suggereert dat de correcte plaatsing van de zeven 
verschillende α-type subeenheden waarschijnlijk niet wordt bepaald door de a-type 
subeenheden zelf, maar dat dit wordt gestuurd door de interactie met specifieke ß-type 
subeenheden. Zeer recent werd deze hypothese gesteund door opheldering van de kristal-
structuur van het gist-proteasoom, waaruit bleek dat sommige α-β en β-β contacten zeer 
specifiek waren. Samenvattend wordt de hypothese voorgesteld dat de stappen (1) en (2) 
in het hierboven beschreven proteasoom-assemblage-model gelijktijdig plaatsvinden, en 
dat de ß-type subeenheden vroeg betrokken zijn bij de correcte plaatsing van de a-type 
C H A P T E R 7 
108 subeenheden. In het cukaryotische assemblage proces zou HsC8 een belangrijke rol kunnen 
spelen bij de initiatie van een vroege stap in de vorming van a-ringen. 
In hoofdstuk 5 wordt de functie van proteasomen tijdens het verloop van de celcyclus onder-
zocht. Er werden vier peptideremmers gebruikt met een verschillend effect op proteasomen 
in vitro, zoals gedeeltelijk in hoofdstuk 5 is aangetoond. Kinetische celcyclus-studies toonden 
aan dat de proteasoomremmer MG115 de Gl -S en de metafase-anafase overgangen blok-
keert en de progressie door de S-fase vertraagt. Het effect van de drie overige remmers was 
evenredig met de capaciteit om de proteolytische activiteit van proteasomen in vitro te 
remmen. Tevens blijkt de remming van MG115 reversibel te zijn. Aangetoond wordt dat 
de activiteit van proteasomen in met MG115 behandelde cellen inderdaad geremd is. 
Deze cellen bevatten een verhoogd niveau geübiquitineerde eiwitten hetgeen bevestigt dat 
de ubiquitine-afhankelijke eiwitafbraak geremd is. Na vergelijking van de in vivo cclcyclus-
effecten met de in vitro proteasoom-remming door MG115, wordt voorgesteld dat de 
chymotrypsinc-achtige activiteit van proteasomen belangrijk is voor de progressie door de 
celcyclus en mogelijk ook voor de ubiquitine-afhankelijke eiwitafbraak in het algemeen. 
Résumé 
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L'un des plus importants systèmes de dégradation des protéines dans les organismes vivants 
est représenté par la voie ubiquirine-protéasome. Ce système protéolytique est non seulement 
impliqué dans le renouvellement protéique, mais aussi dans la dégradation fortement 
régularisée de protéines clés importantes. Ainsi les cibles de la voie ubiquirine-protéasome 
peuvent être des protéines régulatrices qui contrôlent différents mécanismes cellulaires 
importants tels que les voies métaboliques, les réactions inflammatoire et immunitaire, 
l'apoptose et le cycle cellulaire. Les protéines cibles sont marquées pour la dégradation par 
l'accrochage d'une façon covalente de plusieurs exemplaires d'un petit polypeptide très 
conservé: l'ubiquitine. Ces protéines polyubiquitinées sont ensuite dégradées par le 
protéasome 26S. Ce grand complexe se compose d'un protéasome cylindrique 20S, flanqué à 
chacune de ses extrémités d'un complexe régulateur 19S. A l'intérieur du protéasome 20S se 
trouvent les sites protéolytiques tandis que les complexes régulateurs 19S en contrôlent 
l'accès, accrochent l'ubiquitine aux substrats et fournissent l'énergie. Dans cette thèse les 
méthodes de biologie moléculaire sont utilisées pour élucider le rôle des protéasomes dans la 
progression du cycle cellulaire et pour étudier la structure et l'assemblage du protéasome 20S 
humain. 
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110 Le chapitre 1 est une introduction générale, qui présente les connaissances actuelles sur les 
fonctions du protéasome ainsi que ses activité protéolytique, sa structure et son assemblage. 
Le protéasome 20S eucaryotique est constitué par quatre anneaux qui se composent chacun 
de sept sous-unités différentes localisées à des positions déterminées. Les anneaux externes et 
internes sont constitués respectivement par des sous-unités du type α et ß. L'assemblage de 
cette particule oligomérique complexe s'effectue d'une façon très ordonnée. Une méthode 
d'étude de cet assemblage consiste à isoler et à caractériser les intermédiaires de l'assemblage. 
Cependant par cette approche on a pu isoler jusqu'à présent seulement deux intermédiaires 
différents de l'assemblage, à savoir: les complexes 13S (peut-être une moitié de protéasome) 
et les complexes 16S (probablement un dimère immature du complexe 13S). Ces deux 
complexes se représentent assez tardivement dans le système de l'assemblage du protéasome. 
Le modèle actuel d'assemblage eucaryotique établi partiellement sur la découverte de ces 
intermédiaires et sur des données obtenues de l'étude de la formation du protéasome 
archaebactérien comporte les quatre étapes suivantes: (1) la formation d'un anneau de sous-
unités a; (2) l'assemblage de sous-unités ß sur cet anneau α formant ainsi un demi-
protéasome (complexe 13S); (3) la dimérisation de deux demi-protéasomes (intermédiaire 
16S); (4) la maturation en un protéasome fonctionnel (entre autres maturation protéolytique 
des sous-unités ß). Cette thèse décrit une approche différente pour étudier les étapes précoces 
de l'assemblage du protéasome. L'utilisation de sous-unités recombinantes permet d'étudier 
les caractéristiques d'assemblage de sous-unités humaines individuellement ou en 
combinaison. Un tel système a déjà été utilisé pour étudier l'assemblage du protéasome de 
l'archaebactérie Thermoplasma acidophilum (Ta). Le protéasome de T. acidophilum est 
composé de seulement deux sous-unités différentes α et ß chacune en 14 exemplaires. La 
double expression des sous-unités α et ß de Ta dans E. coli permet l'obtention d'une particule 
protéasomale fonctionnelle. L'expression de la seule sous-unité α aboutit à la formation d'une 
structure de deux anneaux tandis que la seule expression de la sous-unité ß forme des 
monomères. 
Le chapitre 2 décrit le clonage de l'ADNc codant la sous-unité ß humaine HsBPROS26. Cet 
ADNc a été isolé par criblage d'une banque d'ADNc humain avec une sonde du gène de 
Xenopus laevis (XLB) homologue de HsBPROS26. L'expression de HsBPROS26 donne une 
protéine monomérique sans activité protéolytique démontrable. Dans le chapitre 3 cette 
étude est étendue à l'expression de la sous-unité α HsC8. La production de la protéine HsC8 
conduit à la formation de complexes d'une grandeur inattendue. L'analyse faite par 
microscopie électronique associée au traitement d'images digitales de ces complexes montre 
que HsC8 s'autoassemble en un double anneau de sept sous-unités qui ressemble beaucoup 
aux complexes de sous-unités α récombinantes de Ta. Ceci est surprenant car les données 
accumulées indiquent que dans le protéasome eucaryotique seule une sous-unité HsC8 est 
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présente par anneau de sous-unités α et que cette sous-unité est accompagnée de deux sous- I I I 
unités voisines bien définies Comme chez Ta l'anneau de sous-unités α joue un rôle dans la 
mise en place et l'assemblage des sous-unités β, nous avons essayé de savoir si la protéine 
HsC8 a une fonction assimilée dans l'assemblage du protéasome humain (cf "general 
introduction" figure 2) Aucune des sous-unités β qu'on a testées n'a formé d'anneau, mais 
toutes s'exprimaient sous des formes allant du monomère au tetramere Contrairement aux 
sous-unités α et β de Τ actdophilum la coexpression de HsC8 avec les sous-unités β ne resuite 
pas à la formation de particules protéasomales fonctionnelles Ces résultats suggèrent que des 
particules qui ressemblent au protéasome et qui se composent de seulement deux sous-unités 
humaines ne peuvent pas être construites Ceci conviendait à la notion que l'assemblage du 
protéasome eucaryote est beaucoup plus complexe que celui du protéasome des 
archaebactenes 
Le rôle de HsC8 dans le processus de l'assemblage semble alors différent du rôle de la sous-
unité a d e Γ actdophilum саг HsC8 ne forme pas de complexes 20S avec des sous-unités 
humaines recombinantes C'est pourquoi dans le chapitre 4 nous abordons le problème du 
rôle de HsC8 dans la formation de l'anneau de sous-unités α Nous nous sommes servis des 
sous-unités α humaines HsPROS30 et HsPROS27 qui sont les voisines naturelles de la 
protéine HsC8 dans le protéasome humain (cf "general introduction" figure 2) Dans le 
chapitre 4 nous montrons d'abord que la possibilité de HsC8 à former des anneaux n'est pas 
une caractéristique génerale de toutes les sous-unités α humaines En effet HsPROS30, ainsi 
que HsPROS27, ne forment que des dimères. Afin de vérifier l'hypothèse que HsC8 a un 
rôle important dans la formation de l'anneau a, peut-être en formant une matrice sur 
laquelle les autres sous-unités α s'assemblent, HsC8 a été exprimée avec HsPROS30 ou 
HsPROS27. Ceci conduit avec les deux sous-unités à la formation d'un anneau hétéro-
oligoménque ressemblant à l'anneau de HsC8 seules. La protéine HsC8 peut alors aider au 
moins à l'assemblage de ses sous-unités voisines en une structure annelée Le rapport entre les 
deux types de sous-unités dans des complexes mixtes fractionnés sur une colonne échangeuse 
d'anion (Sépharose Q), est hétérogène avec des variations importantes de quantité de HsC8 
(de 1/7 à 7/7) On peut conclure de ces résultats que les sous-unités α n'ont apparemment 
pas de sites de liaison qui interagissent de façon sélective entre elles Ceci suggère que le 
positionnement correct des sept sous-unités α différentes dans le protéasome 20S eucaryote 
n'est probablement pas déterminé par les sous-unités α elles-mêmes, mais plutôt dicté par 
l'interaction avec des sous-unités β spécifiques Très récemment cette hypothèse a été 
confirmée par l'elucidation de la structure du protéasome de levure, qui montre que certains 
contacts α-β et β-β sont très spécifiques En résumé nous présumons que les étapes (1) et (2) 
du modèle d'assemblage du protéasome eucaryote décrit ci-dessus sont réalisées 
simultanément et que les sous-unités β sont impliquées dans un stade prématuré dans le 
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I 12 positionnement correct des sous-unités α. Dans l'assemblage eucaryotique HsC8 semble 
avoir un rôle important dans l'initiation de l'étape de formation des anneaux de 
sous-unités a. 
Le chapitre 5 étudie le rôle du protéasomes dans la progression du cycle cellulaire. Nous 
avons utilisé quatre peptides inhibiteurs qui avaient des effets différents sur les activités du 
protéasome in vitro, comme nous avons montré partiellement dans ce chapitre. Des études 
de cinétique cellulaire utilisant un marquage au bromodeoxyuridine révèlent que l'inhibiteur 
MG115 bloque les transitions des phases Gl-S et métaphase-anaphase et retarde l'évolution 
de la phase S. Les effets des trois autres inhibiteurs furent proportionnels à leur capacité 
d'inhiber l'activité protéolytique des protéasomes in vitro. En outre l'inhibition par MG115 
fut réversible. Nous avons démontré que l'activité protéasomale de cellules traitées au 
MG115 a en effet été bloquée. Ces cellules contenaient un taux élevé de protéines 
ubiquitinées, ce qui confirme que la dégradation dépendante de l'ubiquitine est inhibée. 
Après avoir comparé les effets sur le cycle cellulaire in vivo et l'inhibition in vitro par MG115 
nous avons pu émettre l'hypothèse que l'activité "chymotrypsin-like" des protéasomes est 
importante pour la progression du cycle cellulaire et probablement aussi pour la dégradation 
dépendante de l'ubiquitine des protéines en général. 
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